Prescription and Over-the-Counter Drug Product List 39TH EDITION Cumulative Supplement Number 03 : March 2019 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

ABACAVIR SULFATE; LAMIVUDINE TABLET;ORAL ABACAVIR SULFATE AND LAMIVUDINE >A> @ ZYDUS PHARMS EQ 600MG BASE;300MG A 208990 001 Nov 15, 2018 Mar DISC >D> AB ZYDUS PHARMS USA INC EQ 600MG BASE;300MG A 208990 001 Nov 15, 2018 Mar DISC

ACETAZOLAMIDE CAPSULE, EXTENDED RELEASE;ORAL ACETAZOLAMIDE >A> AB CADILA 500MG A 205301 001 Jan 16, 2019 Mar CAHN >D> AB XYLOPIA 500MG A 205301 001 Jan 16, 2019 Mar CAHN

ACETYLCYSTEINE INJECTABLE;INTRAVENOUS ACETYLCYSTEINE >D> AP MYLAN INSTITUTIONAL 6GM/30ML (200MG/ML) A 203624 001 Jun 19, 2015 Mar DISC >A> @ 6GM/30ML (200MG/ML) A 203624 001 Jun 19, 2015 Mar DISC >D> TABLET, EFFERVESCENT;ORAL >D> CETYLEV >D> + ARBOR PHARMS LLC 500MG N 207916 001 Jan 29, 2016 Mar DISC >A> + @ 500MG N 207916 001 Jan 29, 2016 Mar DISC >D> +! 2.5GM N 207916 002 Jan 29, 2016 Mar DISC >A> + @ 2.5GM N 207916 002 Jan 29, 2016 Mar DISC

ACLIDINIUM BROMIDE; FUMARATE >A> POWDER, METERED;INHALATION >A> DUAKLIR PRESSAIR >A> ASTRAZENECA PHARMS 0.4MG/INH;0.012MG/INH N 210595 001 Mar 29, 2019 Mar NEWA

ACYCLOVIR CAPSULE;ORAL ACYCLOVIR >D> AB BOSCOGEN 200MG A 075090 001 Jan 26, 1999 Mar CAHN >A> AB KENTON 200MG A 075090 001 Jan 26, 1999 Mar CAHN >A> OINTMENT;OPHTHALMIC >A> AVACLYR >A> +! FERA PHARMS LLC 3% N 202408 001 Mar 29, 2019 Mar NEWA OINTMENT;TOPICAL ACYCLOVIR >A> AB ZYDUS PHARMS 5% A 205974 001 Mar 15, 2019 Mar NEWA

ADENOSINE INJECTABLE;INJECTION ADENOSINE >D> AP LUITPOLD 3MG/ML A 090010 001 Apr 28, 2009 Mar DISC >A> @ 3MG/ML A 090010 001 Apr 28, 2009 Mar DISC

ALBUTEROL SULFATE TABLET;ORAL ALBUTEROL SULFATE >A> AB AIZANT EQ 2MG BASE A 210948 001 Mar 15, 2019 Mar NEWA >A> AB EQ 4MG BASE A 210948 002 Mar 15, 2019 Mar NEWA

ALISKIREN HEMIFUMARATE TABLET;ORAL >A> ALISKIREN HEMIFUMARATE >A> AB ANCHEN PHARMS EQ 150MG BASE A 206665 001 Mar 22, 2019 Mar NFTG >A> AB EQ 300MG BASE A 206665 002 Mar 22, 2019 Mar NFTG TEKTURNA >D> + NODEN PHARMA EQ 150MG BASE N 021985 001 Mar 05, 2007 Mar CFTG >A> AB + EQ 150MG BASE N 021985 001 Mar 05, 2007 Mar CFTG >D> +! EQ 300MG BASE N 021985 002 Mar 05, 2007 Mar CFTG >A> AB +! EQ 300MG BASE N 021985 002 Mar 05, 2007 Mar CFTG

Page 1 of 30 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

AMBRISENTAN TABLET;ORAL >A> AMBRISENTAN >A> AB MYLAN PHARMS INC 5MG A 208441 001 Mar 28, 2019 Mar NFTG >A> AB 10MG A 208441 002 Mar 28, 2019 Mar NFTG >A> AB PAR PHARM INC 5MG A 209509 001 Apr 10, 2019 Mar NEWA >A> AB 10MG A 209509 002 Apr 10, 2019 Mar NEWA >A> AB SIGMAPHARM LABS LLC 5MG A 208354 001 Apr 10, 2019 Mar NEWA >A> AB 10MG A 208354 002 Apr 10, 2019 Mar NEWA >A> AB SUN PHARM 5MG A 210784 001 Mar 28, 2019 Mar NFTG >A> AB 10MG A 210784 002 Mar 28, 2019 Mar NFTG >A> AB WATSON LABS INC 5MG A 208252 001 Mar 28, 2019 Mar NFTG >A> AB 10MG A 208252 002 Mar 28, 2019 Mar NFTG >A> AB ZYDUS PHARMS 5MG A 210058 001 Mar 28, 2019 Mar NFTG >A> AB 10MG A 210058 002 Mar 28, 2019 Mar NFTG LETAIRIS >D> + GILEAD 5MG N 022081 001 Jun 15, 2007 Mar CFTG >A> AB + 5MG N 022081 001 Jun 15, 2007 Mar CFTG >D> +! 10MG N 022081 002 Jun 15, 2007 Mar CFTG >A> AB +! 10MG N 022081 002 Jun 15, 2007 Mar CFTG

AMLODIPINE BESYLATE; CELECOXIB TABLET;ORAL CONSENSI >A> + COEPTIS EQ 2.5MG BASE;200MG N 210045 001 May 31, 2018 Mar CAHN >A> + EQ 5MG BASE;200MG N 210045 002 May 31, 2018 Mar CAHN >A> +! EQ 10MG BASE;200MG N 210045 003 May 31, 2018 Mar CAHN >D> + KITOV PHARMS LTD EQ 2.5MG BASE;200MG N 210045 001 May 31, 2018 Mar CAHN >D> + EQ 5MG BASE;200MG N 210045 002 May 31, 2018 Mar CAHN >D> +! EQ 10MG BASE;200MG N 210045 003 May 31, 2018 Mar CAHN

AMLODIPINE BESYLATE; OLMESARTAN MEDOXOMIL TABLET;ORAL AMLODIPINE AND OLMESARTAN MEDOXOMIL >D> AB ACCORD HLTHCARE INC EQ 5MG BASE;20MG A 209600 001 Aug 30, 2018 Mar DISC >A> @ EQ 5MG BASE;20MG A 209600 001 Aug 30, 2018 Mar DISC >D> AB EQ 5MG BASE;40MG A 209600 003 Aug 30, 2018 Mar DISC >A> @ EQ 5MG BASE;40MG A 209600 003 Aug 30, 2018 Mar DISC >D> AB EQ 10MG BASE;20MG A 209600 002 Aug 30, 2018 Mar DISC >A> @ EQ 10MG BASE;20MG A 209600 002 Aug 30, 2018 Mar DISC >D> AB EQ 10MG BASE;40MG A 209600 004 Aug 30, 2018 Mar DISC >A> @ EQ 10MG BASE;40MG A 209600 004 Aug 30, 2018 Mar DISC

ANASTROZOLE TABLET;ORAL ANASTROZOLE >D> AB BOSCOGEN 1MG A 078944 001 Jun 28, 2010 Mar CAHN >A> AB KENTON 1MG A 078944 001 Jun 28, 2010 Mar CAHN

ARMODAFINIL TABLET;ORAL ARMODAFINIL >A> AB APOTEX INC 50MG A 201514 001 Mar 25, 2019 Mar NEWA >A> AB 150MG A 201514 002 Mar 25, 2019 Mar NEWA >A> AB 250MG A 201514 003 Mar 25, 2019 Mar NEWA >A> AB AUROBINDO PHARMA LTD 200MG A 206069 004 Dec 07, 2018 Mar NEWA

ASPIRIN; DIPYRIDAMOLE CAPSULE, EXTENDED RELEASE;ORAL ASPIRIN AND DIPYRIDAMOLE >A> AB LANNETT CO INC 25MG;200MG A 204552 001 Mar 20, 2019 Mar NEWA

ATOMOXETINE HYDROCHLORIDE CAPSULE;ORAL ATOMOXETINE HYDROCHLORIDE >D> @ ZYDUS PHARMS USA INC 18MG A 079017 001 Sep 17, 2010 Mar CMFD >A> AB 18MG A 079017 001 Sep 17, 2010 Mar CMFD >D> @ 25MG A 079017 002 Sep 17, 2010 Mar CMFD >A> AB 25MG A 079017 002 Sep 17, 2010 Mar CMFD >D> @ 40MG A 079017 003 Sep 17, 2010 Mar CMFD

Page 2 of 30 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

ATOMOXETINE HYDROCHLORIDE CAPSULE;ORAL ATOMOXETINE HYDROCHLORIDE >A> AB 40MG A 079017 003 Sep 17, 2010 Mar CMFD >D> @ 60MG A 079017 004 Sep 17, 2010 Mar CMFD >A> AB 60MG A 079017 004 Sep 17, 2010 Mar CMFD >D> @ 80MG A 079017 005 Sep 17, 2010 Mar CMFD >A> AB 80MG A 079017 005 Sep 17, 2010 Mar CMFD >D> @ 100MG A 079017 006 Sep 17, 2010 Mar CMFD >A> AB 100MG A 079017 006 Sep 17, 2010 Mar CMFD

ATROPINE >D> INJECTABLE;INJECTION >D> >D> @ ABBVIE EQ 2MG SULFATE/0.7ML A 071295 001 Jan 30, 1987 Mar CDFR SOLUTION;INTRAMUSCULAR ATROPEN >A> +! MERIDIAN MEDCL TECHN EQ 0.25MG SULFATE/0.3ML N 017106 004 Sep 17, 2004 Mar CPOT >A> +! EQ 0.5MG SULFATE/0.7ML N 017106 003 Jun 19, 2003 Mar CPOT >A> +! EQ 1MG SULFATE/0.7ML N 017106 002 Jun 19, 2003 Mar CPOT >A> +! EQ 2MG SULFATE/0.7ML N 017106 001 May 15, 1973 Mar CPOT >A> ATROPINE >A> @ ABBVIE EQ 2MG SULFATE/0.7ML A 071295 001 Jan 30, 1987 Mar CDFR

ATROPINE SULFATE SOLUTION;INTRAMUSCULAR ATROPEN >D> +! MERIDIAN MEDCL TECHN 0.25MG/0.3ML N 017106 004 Sep 17, 2004 Mar CPOT >D> +! 0.5MG/0.7ML N 017106 003 Jun 19, 2003 Mar CPOT >D> +! 1MG/0.7ML N 017106 002 Jun 19, 2003 Mar CPOT >D> +! 2MG/0.7ML N 017106 001 May 15, 1973 Mar CPOT

AZELASTINE HYDROCHLORIDE SOLUTION/DROPS;OPHTHALMIC AZELASTINE HYDROCHLORIDE >A> AT ALEMBIC PHARMS LTD 0.05% A 209620 001 Mar 20, 2019 Mar NEWA >A> AT SOMERSET THERAPS LLC 0.05% A 207411 001 Mar 29, 2019 Mar NEWA

BELINOSTAT POWDER;INTRAVENOUS BELEODAQ >A> +! ACROTECH 500MG/VIAL N 206256 001 Jul 03, 2014 Mar CAHN >D> +! SPECTRUM PHARMS 500MG/VIAL N 206256 001 Jul 03, 2014 Mar CAHN

BENZOYL PEROXIDE; CLINDAMYCIN PHOSPHATE GEL;TOPICAL CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE >A> AB GLENMARK PHARMS 5%;1% BASE A 209252 001 Mar 14, 2019 Mar NEWA

BENZTROPINE MESYLATE TABLET;ORAL BENZTROPINE MESYLATE >D> OXFORD PHARMS 0.5MG A 040706 002 Feb 14, 2008 Mar DISC >A> @ 0.5MG A 040706 002 Feb 14, 2008 Mar DISC >D> 1MG A 040706 003 Feb 14, 2008 Mar DISC >A> @ 1MG A 040706 003 Feb 14, 2008 Mar DISC

BEPOTASTINE BESILATE SOLUTION/DROPS;OPHTHALMIC BEPOTASTINE BESILATE >A> AT MICRO LABS 1.5% A 206220 001 Mar 18, 2019 Mar NEWA

BETAMETHASONE DIPROPIONATE SPRAY;TOPICAL SERNIVO >A> +! ENCORE DERMAT EQ 0.05% BASE/SPRAY N 208079 001 Feb 05, 2016 Mar CAHN >D> +! PROMIUS PHARMA LLC EQ 0.05% BASE/SPRAY N 208079 001 Feb 05, 2016 Mar CAHN

Page 3 of 30 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

>A> DIPROPIONATE; CALCIPOTRIENE >A> OINTMENT;TOPICAL >A> CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE >A> AB PERRIGO ISRAEL 0.064%;0.005% A 200174 001 Dec 12, 2014 Mar CAIN >A> AB TOLMAR 0.064%;0.005% A 201615 001 Jan 14, 2013 Mar CAIN >A> TACLONEX >A> AB +! LEO PHARMA AS 0.064%;0.005% N 021852 001 Jan 09, 2006 Mar CAIN >A> SUSPENSION;TOPICAL >A> TACLONEX >A> +! LEO PHARMA AS 0.064%;0.005% N 022185 001 May 09, 2008 Mar CAIN

>D> BETAMETHASONE DIPROPIONATE; CALCIPOTRIENE HYDRATE >D> OINTMENT;TOPICAL >D> CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE >D> AB PERRIGO ISRAEL 0.064%;0.005% A 200174 001 Dec 12, 2014 Mar CAIN >D> AB TOLMAR 0.064%;0.005% A 201615 001 Jan 14, 2013 Mar CAIN >D> TACLONEX >D> AB +! LEO PHARMA AS 0.064%;0.005% N 021852 001 Jan 09, 2006 Mar CAIN >D> SUSPENSION;TOPICAL >D> TACLONEX >D> +! LEO PHARMA AS 0.064%;0.005% N 022185 001 May 09, 2008 Mar CAIN

BETHANECHOL CHLORIDE TABLET;ORAL DUVOID >D> AA BI-COASTAL PHARMA 10MG A 086262 001 Mar 22, 1978 Mar CAHN >D> AA 25MG A 086263 001 Mar 22, 1978 Mar CAHN >D> AA 50MG A 085882 003 Mar 22, 1978 Mar CAHN >A> AA CHARTWELL RX 10MG A 086262 001 Mar 22, 1978 Mar CAHN >A> AA 25MG A 086263 001 Mar 22, 1978 Mar CAHN >A> AA 50MG A 085882 003 Mar 22, 1978 Mar CAHN

BIMATOPROST SOLUTION/DROPS;OPHTHALMIC BIMATOPROST >A> AT GLAND PHARMA LTD 0.03% A 210126 001 Mar 22, 2019 Mar NEWA

BORTEZOMIB >D> POWDER;INTRAVENOUS, SUBCUTANEOUS >D> BORTEZOMIB >D> + HOSPIRA INC 1MG/VIAL N 209191 002 Dec 28, 2018 Mar DISC >A> + @ 1MG/VIAL N 209191 002 Dec 28, 2018 Mar DISC

BUDESONIDE TABLET, EXTENDED RELEASE;ORAL UCERIS >A> AB +! SALIX 9MG N 203634 001 Jan 14, 2013 Mar CAHN >D> AB +! VALEANT PHARMS INTL 9MG N 203634 001 Jan 14, 2013 Mar CAHN

BUPIVACAINE HYDROCHLORIDE INJECTABLE;SPINAL BUPIVACAINE HYDROCHLORIDE >A> AP B BRAUN MEDICAL INC 0.75% A 209087 001 Apr 02, 2019 Mar NEWA

BUPRENORPHINE HYDROCHLORIDE; NALOXONE HYDROCHLORIDE FILM;SUBLINGUAL >D> CASSIPA >D> +! TEVA PHARMS USA EQ 16MG BASE;EQ 4MG BASE N 208042 001 Sep 07, 2018 Mar DISC >A> + @ EQ 16MG BASE;EQ 4MG BASE N 208042 001 Sep 07, 2018 Mar DISC

CAFFEINE CITRATE SOLUTION;ORAL CAFFEINE CITRATE >D> AA LUITPOLD EQ 30MG BASE/3ML (EQ 10MG A 090064 001 Nov 20, 2009 Mar DISC BASE/ML) >A> @ EQ 30MG BASE/3ML (EQ 10MG A 090064 001 Nov 20, 2009 Mar DISC BASE/ML)

Page 4 of 30 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

CARBINOXAMINE MALEATE TABLET;ORAL MALEATE >D> MIKART 6MG A 207484 001 May 31, 2016 Mar CHRS >A> ! 6MG A 207484 001 May 31, 2016 Mar CHRS

CARBOPLATIN >A> INJECTABLE;INTRAVENOUS >A> CARBOPLATIN >A> @ ACTAVIS TOTOWA 50MG/5ML (10MG/ML) A 078732 001 Feb 06, 2012 Mar CDFR >A> @ 150MG/15ML (10MG/ML) A 078732 002 Feb 06, 2012 Mar CDFR >A> @ 450MG/45ML (10MG/ML) A 078732 003 Feb 06, 2012 Mar CDFR >A> @ 600MG/60ML (10MG/ML) A 078732 004 Feb 06, 2012 Mar CDFR >A> @ FRESENIUS KABI USA 50MG/5ML (10MG/ML) A 077247 001 Oct 21, 2004 Mar CDFR >A> @ 50MG/5ML (10MG/ML) A 077266 001 Feb 15, 2006 Mar CDFR >A> @ 150MG/15ML (10MG/ML) A 077247 002 Oct 21, 2004 Mar CDFR >A> @ 150MG/15ML (10MG/ML) A 077266 002 Feb 15, 2006 Mar CDFR >A> AP 450MG/45ML (10MG/ML) A 077247 003 Oct 21, 2004 Mar CDFR >A> @ MYLAN LABS LTD 1GM/100ML (10MG/ML) A 091478 001 Nov 23, 2011 Mar CDFR >A> @ PHARMACHEMIE BV 50MG/5ML (10MG/ML) A 077679 001 Feb 25, 2009 Mar CDFR >A> @ 150MG/15ML (10MG/ML) A 077679 002 Feb 25, 2009 Mar CDFR >A> @ 450MG/45ML (10MG/ML) A 077679 003 Feb 25, 2009 Mar CDFR >A> @ TEVA PARENTERAL 50MG/5ML (10MG/ML) A 077389 001 Mar 30, 2007 Mar CDFR >A> @ 150MG/15ML (10MG/ML) A 077389 002 Mar 30, 2007 Mar CDFR >A> @ 450MG/45ML (10MG/ML) A 077389 003 Mar 30, 2007 Mar CDFR >A> PARAPLATIN >A> + @ CORDENPHARMA 50MG/5ML (10MG/ML) N 020452 001 Jul 14, 2003 Mar CDFR >A> + @ 150MG/15ML (10MG/ML) N 020452 002 Jul 14, 2003 Mar CDFR >A> + @ 450MG/45ML (10MG/ML) N 020452 003 Jul 14, 2003 Mar CDFR >A> + @ 600MG/60ML (10MG/ML) N 020452 004 Jan 15, 2004 Mar CDFR >D> INJECTABLE;IV (INFUSION) >D> CARBOPLATIN >D> @ ACTAVIS TOTOWA 50MG/5ML (10MG/ML) A 078732 001 Feb 06, 2012 Mar CDFR >D> @ 150MG/15ML (10MG/ML) A 078732 002 Feb 06, 2012 Mar CDFR >D> @ 450MG/45ML (10MG/ML) A 078732 003 Feb 06, 2012 Mar CDFR >D> @ 600MG/60ML (10MG/ML) A 078732 004 Feb 06, 2012 Mar CDFR >D> @ FRESENIUS KABI USA 50MG/5ML (10MG/ML) A 077247 001 Oct 21, 2004 Mar CDFR >D> @ 50MG/5ML (10MG/ML) A 077266 001 Feb 15, 2006 Mar CDFR >D> @ 150MG/15ML (10MG/ML) A 077247 002 Oct 21, 2004 Mar CDFR >D> @ 150MG/15ML (10MG/ML) A 077266 002 Feb 15, 2006 Mar CDFR >D> AP 450MG/45ML (10MG/ML) A 077247 003 Oct 21, 2004 Mar CDFR >D> AP MYLAN INSTITUTIONAL 50MG/5ML (10MG/ML) A 077998 001 Apr 24, 2007 Mar DISC >A> @ 50MG/5ML (10MG/ML) A 077998 001 Apr 24, 2007 Mar DISC >D> AP 150MG/15ML (10MG/ML) A 077998 002 Apr 24, 2007 Mar DISC >A> @ 150MG/15ML (10MG/ML) A 077998 002 Apr 24, 2007 Mar DISC >D> AP 450MG/45ML (10MG/ML) A 077998 003 Apr 24, 2007 Mar DISC >A> @ 450MG/45ML (10MG/ML) A 077998 003 Apr 24, 2007 Mar DISC >D> @ MYLAN LABS LTD 1GM/100ML (10MG/ML) A 091478 001 Nov 23, 2011 Mar CDFR >D> @ PHARMACHEMIE BV 50MG/5ML (10MG/ML) A 077679 001 Feb 25, 2009 Mar CDFR >D> @ 150MG/15ML (10MG/ML) A 077679 002 Feb 25, 2009 Mar CDFR >D> @ 450MG/45ML (10MG/ML) A 077679 003 Feb 25, 2009 Mar CDFR >D> @ TEVA PARENTERAL 50MG/5ML (10MG/ML) A 077389 001 Mar 30, 2007 Mar CDFR >D> @ 150MG/15ML (10MG/ML) A 077389 002 Mar 30, 2007 Mar CDFR >D> @ 450MG/45ML (10MG/ML) A 077389 003 Mar 30, 2007 Mar CDFR >D> PARAPLATIN >D> @ CORDENPHARMA 50MG/5ML (10MG/ML) N 020452 001 Jul 14, 2003 Mar CDFR >D> @ 150MG/15ML (10MG/ML) N 020452 002 Jul 14, 2003 Mar CDFR >D> @ 450MG/45ML (10MG/ML) N 020452 003 Jul 14, 2003 Mar CDFR >D> @ 600MG/60ML (10MG/ML) N 020452 004 Jan 15, 2004 Mar CDFR

CARMUSTINE INJECTABLE;INJECTION CARMUSTINE >A> AP STI PHARMA LLC 100MG/VIAL A 209278 001 Apr 02, 2019 Mar NEWA

Page 5 of 30 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

CEPHALEXIN FOR SUSPENSION;ORAL CEPHALEXIN >A> AB ALKEM LABS LTD EQ 125MG BASE/5ML A 210221 001 Mar 26, 2019 Mar NEWA >A> AB EQ 250MG BASE/5ML A 210221 002 Mar 26, 2019 Mar NEWA

CERITINIB >A> TABLET;ORAL >A> ZYKADIA >A> +! NOVARTIS PHARMS CORP 150MG N 211225 001 Mar 18, 2019 Mar NEWA

CHLORDIAZEPOXIDE HYDROCHLORIDE INJECTABLE;INJECTION LIBRIUM >A> @ BAUSCH 100MG/AMP N 012301 001 Jul 21, 1961 Mar CAHN >D> @ VALEANT PHARMS LLC 100MG/AMP N 012301 001 Jul 21, 1961 Mar CAHN

CICLESONIDE AEROSOL, METERED;INHALATION ALVESCO >D> +! ASTRAZENECA PHARMS 0.08MG/INH N 021658 002 Jan 10, 2008 Mar CAHN >D> +! 0.16MG/INH N 021658 003 Jan 10, 2008 Mar CAHN >A> +! COVIS PHARMA BV 0.08MG/INH N 021658 002 Jan 10, 2008 Mar CAHN >A> +! 0.16MG/INH N 021658 003 Jan 10, 2008 Mar CAHN AEROSOL, METERED;NASAL ZETONNA >D> +! ASTRAZENECA PHARMS 0.037MG/INH N 202129 001 Jan 20, 2012 Mar CAHN >A> +! COVIS PHARMA BV 0.037MG/INH N 202129 001 Jan 20, 2012 Mar CAHN SPRAY, METERED;NASAL OMNARIS >D> +! ASTRAZENECA PHARMS 0.05MG/INH N 022004 001 Oct 20, 2006 Mar CAHN >A> +! COVIS PHARMA BV 0.05MG/INH N 022004 001 Oct 20, 2006 Mar CAHN

CLADRIBINE >A> TABLET;ORAL >A> MAVENCLAD >A> +! EMD SERONO INC 10MG N 022561 001 Mar 29, 2019 Mar NEWA

CLINDAMYCIN PALMITATE HYDROCHLORIDE FOR SOLUTION;ORAL CLINDAMYCIN PALMITATE HYDROCHLORIDE >D> AA MYLAN PHARMS INC EQ 75MG BASE/5ML A 203063 001 May 25, 2016 Mar DISC >A> @ EQ 75MG BASE/5ML A 203063 001 May 25, 2016 Mar DISC

CLOMIPRAMINE HYDROCHLORIDE CAPSULE;ORAL HYDROCHLORIDE >A> AB MANKIND PHARMA 25MG A 211767 001 Apr 08, 2019 Mar NEWA >A> AB 50MG A 211767 002 Apr 08, 2019 Mar NEWA >A> AB 75MG A 211767 003 Apr 08, 2019 Mar NEWA

CODEINE SULFATE SOLUTION;ORAL CODEINE SULFATE >A> @ HIKMA 30MG/5ML N 202245 001 Jun 30, 2011 Mar CAHN >D> @ WEST-WARD PHARMS INT 30MG/5ML N 202245 001 Jun 30, 2011 Mar CAHN TABLET;ORAL CODEINE SULFATE >A> AB + HIKMA 15MG N 022402 001 Jul 16, 2009 Mar CAHN >A> AB + 30MG N 022402 002 Jul 16, 2009 Mar CAHN >A> AB +! 60MG N 022402 003 Jul 16, 2009 Mar CAHN >D> AB + WEST-WARD PHARMS INT 15MG N 022402 001 Jul 16, 2009 Mar CAHN >D> AB + 30MG N 022402 002 Jul 16, 2009 Mar CAHN >D> AB +! 60MG N 022402 003 Jul 16, 2009 Mar CAHN

COLESEVELAM HYDROCHLORIDE FOR SUSPENSION;ORAL COLESEVELAM HYDROCHLORIDE >D> AB GLENMARK PHARMS LTD 1.875GM/PACKET A 202190 001 Jul 16, 2018 Mar CTEC >A> 1.875GM/PACKET A 202190 001 Jul 16, 2018 Mar CTEC

Page 6 of 30 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

COLESEVELAM HYDROCHLORIDE FOR SUSPENSION;ORAL WELCHOL >D> AB + DAIICHI SANKYO 1.875GM/PACKET N 022362 001 Oct 02, 2009 Mar DISC >A> + @ 1.875GM/PACKET N 022362 001 Oct 02, 2009 Mar DISC

CROMOLYN SODIUM SOLUTION;INHALATION CROMOLYN SODIUM >D> AN MYLAN SPECIALITY LP 10MG/ML A 074209 001 Apr 26, 1994 Mar DISC >A> @ 10MG/ML A 074209 001 Apr 26, 1994 Mar DISC

CYCLOBENZAPRINE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE;ORAL AMRIX >D> + TEVA PHARMS INTL 15MG N 021777 001 Feb 01, 2007 Mar CTEC >A> AB + 15MG N 021777 001 Feb 01, 2007 Mar CTEC >D> +! 30MG N 021777 002 Feb 01, 2007 Mar CTEC >A> AB +! 30MG N 021777 002 Feb 01, 2007 Mar CTEC HYDROCHLORIDE >D> @ TWI PHARMS INC 15MG A 091281 001 Jan 31, 2013 Mar CMFD >A> AB 15MG A 091281 001 Jan 31, 2013 Mar CMFD >D> @ 30MG A 091281 002 Jan 31, 2013 Mar CMFD >A> AB 30MG A 091281 002 Jan 31, 2013 Mar CMFD

DACTINOMYCIN INJECTABLE;INJECTION DACTINOMYCIN >D> AP LUITPOLD 0.5MG/VIAL A 202562 001 Aug 23, 2013 Mar DISC >A> @ 0.5MG/VIAL A 202562 001 Aug 23, 2013 Mar DISC

DANTROLENE SODIUM INJECTABLE;INJECTION DANTROLENE SODIUM >D> AP MYLAN INSTITUTIONAL 20MG/VIAL A 205239 001 Feb 18, 2016 Mar DISC >A> @ 20MG/VIAL A 205239 001 Feb 18, 2016 Mar DISC

DAPTOMYCIN POWDER;INTRAVENOUS DAPTOMYCIN >D> AP CRANE PHARMS LLC 500MG/VIAL A 206005 001 Jun 15, 2016 Mar CAHN >A> AP XELLIA PHARMS APS 500MG/VIAL A 206005 001 Jun 15, 2016 Mar CAHN

DECITABINE INJECTABLE;INTRAVENOUS DECITABINE >A> AP WOCKHARDT BIO AG 50MG/VIAL A 209056 001 Apr 09, 2019 Mar NEWA

DESMOPRESSIN ACETATE INJECTABLE;INJECTION DESMOPRESSIN ACETATE >D> @ TEVA PHARMS USA 0.004MG/ML A 074888 001 Oct 15, 1997 Mar CMFD >A> AP 0.004MG/ML A 074888 001 Oct 15, 1997 Mar CMFD

DESOGESTREL; ETHINYL ESTRADIOL TABLET;ORAL-28 DESOGESTREL AND ETHINYL ESTRADIOL >D> AB ACCORD HLTHCARE 0.15MG;0.03MG A 207067 001 Sep 13, 2018 Mar DISC >A> @ 0.15MG;0.03MG A 207067 001 Sep 13, 2018 Mar DISC

DESVENLAFAXINE SUCCINATE TABLET, EXTENDED RELEASE;ORAL DESVENLAFAXINE SUCCINATE >D> AB YICHANG HUMANWELL EQ 50MG BASE A 210014 001 Oct 01, 2018 Mar DISC >A> @ EQ 50MG BASE A 210014 001 Oct 01, 2018 Mar DISC >D> AB EQ 100MG BASE A 210014 002 Oct 01, 2018 Mar DISC >A> @ EQ 100MG BASE A 210014 002 Oct 01, 2018 Mar DISC

Page 7 of 30 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

DEXMEDETOMIDINE HYDROCHLORIDE INJECTABLE;INJECTION DEXMEDETOMIDINE HYDROCHLORIDE >D> AP LUITPOLD EQ 200MCG BASE/2ML (EQ 100MCG A 203773 001 May 12, 2017 Mar DISC BASE/ML) >A> @ EQ 200MCG BASE/2ML (EQ 100MCG A 203773 001 May 12, 2017 Mar DISC BASE/ML) SOLUTION;INTRAVENOUS DEXMEDETOMIDINE HYDROCHLORIDE >D> + HQ SPCLT PHARMA EQ 200MG BASE/50ML (EQ 4MCG N 206628 003 Jun 22, 2018 Mar CPOT BASE/ML) >A> + EQ 200MCG BASE/50ML (EQ 4MCG N 206628 003 Jun 22, 2018 Mar CPOT BASE/ML) >D> + EQ 400MG BASE/100ML (EQ 4MCG N 206628 004 Jun 22, 2018 Mar CPOT BASE/ML) >A> + EQ 400MCG BASE/100ML (EQ 4MCG N 206628 004 Jun 22, 2018 Mar CPOT BASE/ML)

DIAZEPAM INJECTABLE;INJECTION DIAZEPAM >A> AP BELOTECA INC 10MG/2ML (5MG/ML) A 210363 001 Mar 18, 2019 Mar NEWA >D> ! HOSPIRA 10MG/2ML (5MG/ML) A 072079 001 Dec 20, 1988 Mar CTEC >A> AP ! 10MG/2ML (5MG/ML) A 072079 001 Dec 20, 1988 Mar CTEC

DILTIAZEM HYDROCHLORIDE CAPSULE, EXTENDED RELEASE;ORAL DILTIAZEM HYDROCHLORIDE >D> AB3 PAR PHARM 360MG A 209766 001 May 30, 2018 Mar DISC >A> @ 360MG A 209766 001 May 30, 2018 Mar DISC TABLET, EXTENDED RELEASE;ORAL CARDIZEM LA >A> AB + BAUSCH 120MG N 021392 001 Feb 06, 2003 Mar CAHN >A> AB + 180MG N 021392 002 Feb 06, 2003 Mar CAHN >A> AB + 240MG N 021392 003 Feb 06, 2003 Mar CAHN >A> AB + 300MG N 021392 004 Feb 06, 2003 Mar CAHN >A> AB + 360MG N 021392 005 Feb 06, 2003 Mar CAHN >A> AB +! 420MG N 021392 006 Feb 06, 2003 Mar CAHN >D> AB + VALEANT INTL 120MG N 021392 001 Feb 06, 2003 Mar CAHN >D> AB + 180MG N 021392 002 Feb 06, 2003 Mar CAHN >D> AB + 240MG N 021392 003 Feb 06, 2003 Mar CAHN >D> AB + 300MG N 021392 004 Feb 06, 2003 Mar CAHN >D> AB + 360MG N 021392 005 Feb 06, 2003 Mar CAHN >D> AB +! 420MG N 021392 006 Feb 06, 2003 Mar CAHN TABLET;ORAL CARDIZEM >A> AB + BAUSCH 30MG N 018602 001 Nov 05, 1982 Mar CAHN >A> AB + 60MG N 018602 002 Nov 05, 1982 Mar CAHN >A> AB + 90MG N 018602 003 Dec 08, 1986 Mar CAHN >A> AB +! 120MG N 018602 004 Dec 08, 1986 Mar CAHN >D> AB + VALEANT INTL 30MG N 018602 001 Nov 05, 1982 Mar CAHN >D> AB + 60MG N 018602 002 Nov 05, 1982 Mar CAHN >D> AB + 90MG N 018602 003 Dec 08, 1986 Mar CAHN >D> AB +! 120MG N 018602 004 Dec 08, 1986 Mar CAHN

DIMETHYL SULFOXIDE SOLUTION;INTRAVESICAL DIMETHYL SULFOXIDE >D> AT MYLAN INSTITUTIONAL 50% A 076185 001 Nov 29, 2002 Mar DISC >A> @ 50% A 076185 001 Nov 29, 2002 Mar DISC RIMSO-50 >D> AT +! MYLAN INSTITUTIONAL 50% N 017788 001 Apr 04, 1978 Mar CTEC >A> +! 50% N 017788 001 Apr 04, 1978 Mar CTEC

DOCETAXEL INJECTABLE;INJECTION DOCETAXEL >D> AP CIPLA 20MG/2ML (10MG/ML) A 209634 001 Aug 24, 2018 Mar DISC >A> @ 20MG/2ML (10MG/ML) A 209634 001 Aug 24, 2018 Mar DISC >D> AP 80MG/8ML (10MG/ML) A 209634 002 Aug 24, 2018 Mar DISC >A> @ 80MG/8ML (10MG/ML) A 209634 002 Aug 24, 2018 Mar DISC >D> AP 160MG/16ML (10MG/ML) A 209634 003 Aug 24, 2018 Mar DISC

Page 8 of 30 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

DOCETAXEL INJECTABLE;INJECTION DOCETAXEL >A> @ 160MG/16ML (10MG/ML) A 209634 003 Aug 24, 2018 Mar DISC >D> AP EAGLE PHARMS 20MG/ML (20MG/ML) N 205934 001 Dec 22, 2015 Mar CAHN >D> AP 80MG/4ML (20MG/ML) N 205934 002 Dec 22, 2015 Mar CAHN >D> AP 160MG/8ML (20MG/ML) N 205934 003 Dec 22, 2015 Mar CAHN >A> AP MYLAN LABS LTD 160MG/8ML (20MG/ML) A 208137 001 Apr 01, 2019 Mar NEWA >A> AP TEIKOKU PHARMA 20MG/ML (20MG/ML) N 205934 001 Dec 22, 2015 Mar CAHN >A> AP 80MG/4ML (20MG/ML) N 205934 002 Dec 22, 2015 Mar CAHN >A> AP 160MG/8ML (20MG/ML) N 205934 003 Dec 22, 2015 Mar CAHN

DONEPEZIL HYDROCHLORIDE TABLET;ORAL DONEPEZIL HYDROCHLORIDE >A> AB CADILA 5MG A 090100 001 Oct 24, 2012 Mar CAHN >A> AB 10MG A 090100 002 Oct 24, 2012 Mar CAHN >D> AB OSMOTICA PHARM US 23MG A 203114 001 Jan 26, 2016 Mar DISC >A> @ 23MG A 203114 001 Jan 26, 2016 Mar DISC >D> AB ZYDUS PHARMS USA INC 5MG A 090100 001 Oct 24, 2012 Mar CAHN >D> AB 10MG A 090100 002 Oct 24, 2012 Mar CAHN

DORZOLAMIDE HYDROCHLORIDE SOLUTION/DROPS;OPHTHALMIC DORZOLAMIDE HYDROCHLORIDE >D> AT LUITPOLD EQ 2% BASE A 079186 001 Nov 18, 2009 Mar DISC >A> @ EQ 2% BASE A 079186 001 Nov 18, 2009 Mar DISC

DOXAPRAM HYDROCHLORIDE INJECTABLE;INJECTION DOPRAM >A> AP +! HIKMA 20MG/ML N 014879 001 Jun 23, 1965 Mar CAHN >D> AP +! WEST-WARD PHARMS INT 20MG/ML N 014879 001 Jun 23, 1965 Mar CAHN

DOXEPIN HYDROCHLORIDE CAPSULE;ORAL HYDROCHLORIDE >A> AB AUROBINDO PHARMA LTD EQ 10MG BASE A 211603 001 Mar 27, 2019 Mar NEWA >A> AB EQ 25MG BASE A 211603 002 Mar 27, 2019 Mar NEWA >A> AB EQ 50MG BASE A 211603 003 Mar 27, 2019 Mar NEWA >A> AB EQ 75MG BASE A 211603 004 Mar 27, 2019 Mar NEWA >A> AB EQ 100MG BASE A 211603 005 Mar 27, 2019 Mar NEWA

DOXYCYCLINE HYCLATE CAPSULE;ORAL DOXYCYCLINE HYCLATE >D> AB AJANTA PHARMA LTD EQ 50MG BASE A 211012 001 Sep 24, 2018 Mar DISC >A> @ EQ 50MG BASE A 211012 001 Sep 24, 2018 Mar DISC >D> AB EQ 100MG BASE A 211012 002 Sep 24, 2018 Mar DISC >A> @ EQ 100MG BASE A 211012 002 Sep 24, 2018 Mar DISC

DROSPIRENONE; ETHINYL ESTRADIOL TABLET;ORAL DROSPIRENONE AND ETHINYL ESTRADIOL >A> AB HETERO LABS LTD 3MG;0.02MG A 211944 001 Mar 22, 2019 Mar NEWA

EFAVIRENZ; LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE TABLET;ORAL EFAVIRENZ, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE >A> MACLEODS PHARMS LTD 400MG;300MG;300MG N 210649 001 Mar 15, 2019 Mar NEWA

ENALAPRIL MALEATE >D> FOR SOLUTION;ORAL >D> EPANED KIT >D> +! SILVERGATE PHARMS 1MG/ML N 204308 001 Aug 13, 2013 Mar DISC >A> + @ 1MG/ML N 204308 001 Aug 13, 2013 Mar DISC TABLET;ORAL VASOTEC >A> AB + BAUSCH 2.5MG N 018998 005 Jul 26, 1988 Mar CAHN >A> AB + 5MG N 018998 001 Dec 24, 1985 Mar CAHN >A> AB + 10MG N 018998 002 Dec 24, 1985 Mar CAHN

Page 9 of 30 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

ENALAPRIL MALEATE TABLET;ORAL VASOTEC >A> AB +! 20MG N 018998 003 Dec 24, 1985 Mar CAHN >D> AB + VALEANT PHARMS NORTH 2.5MG N 018998 005 Jul 26, 1988 Mar CAHN >D> AB + 5MG N 018998 001 Dec 24, 1985 Mar CAHN >D> AB + 10MG N 018998 002 Dec 24, 1985 Mar CAHN >D> AB +! 20MG N 018998 003 Dec 24, 1985 Mar CAHN

ENALAPRIL MALEATE; HYDROCHLOROTHIAZIDE TABLET;ORAL VASERETIC >A> AB + BAUSCH 5MG;12.5MG N 019221 003 Jul 12, 1995 Mar CAHN >A> AB +! 10MG;25MG N 019221 001 Oct 31, 1986 Mar CAHN >D> AB + VALEANT INTL 5MG;12.5MG N 019221 003 Jul 12, 1995 Mar CAHN >D> AB +! 10MG;25MG N 019221 001 Oct 31, 1986 Mar CAHN

ENOXAPARIN SODIUM INJECTABLE;INTRAVENOUS, SUBCUTANEOUS ENOXAPARIN SODIUM >A> AB AMPHASTAR PHARMS INC 300MG/3ML (100MG/ML) A 208600 001 Mar 14, 2019 Mar NEWA

ENTECAVIR TABLET;ORAL ENTECAVIR >A> AB MYLAN PHARMS INC 0.5MG A 206226 001 Mar 26, 2019 Mar NEWA >A> AB 1MG A 206226 002 Mar 26, 2019 Mar NEWA

EPINEPHRINE INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS EPINEPHRINE (AUTOINJECTOR) >D> AB TEVA PHARMS USA 0.15MG/DELIVERY A 090589 002 Aug 16, 2018 Mar DISC >A> @ 0.15MG/DELIVERY A 090589 002 Aug 16, 2018 Mar DISC EPIPEN JR. >D> AB +! MYLAN SPECIALITY LP 0.15MG/DELIVERY N 019430 002 Dec 22, 1987 Mar CTEC >A> +! 0.15MG/DELIVERY N 019430 002 Dec 22, 1987 Mar CTEC

EPIRUBICIN HYDROCHLORIDE INJECTABLE;INJECTION EPIRUBICIN HYDROCHLORIDE >D> AP FRESENIUS KABI USA 150MG/75ML (2MG/ML) A 065408 003 Oct 15, 2007 Mar CTEC >A> 150MG/75ML (2MG/ML) A 065408 003 Oct 15, 2007 Mar CTEC >D> AP HOSPIRA 10MG/5ML (2MG/ML) A 065343 001 Apr 19, 2007 Mar DISC >A> @ 10MG/5ML (2MG/ML) A 065343 001 Apr 19, 2007 Mar DISC >D> AP 150MG/75ML (2MG/ML) A 065343 003 Apr 19, 2007 Mar DISC >A> @ 150MG/75ML (2MG/ML) A 065343 003 Apr 19, 2007 Mar DISC >D> AP 200MG/100ML (2MG/ML) A 065343 004 Apr 19, 2007 Mar DISC >A> @ 200MG/100ML (2MG/ML) A 065343 004 Apr 19, 2007 Mar DISC

EPTIFIBATIDE INJECTABLE;INJECTION EPTIFIBATIDE >A> AP USV 2MG/ML A 204361 001 Mar 14, 2019 Mar NEWA >A> AP 75MG/100ML A 204361 002 Mar 14, 2019 Mar NEWA

ERLOTINIB HYDROCHLORIDE TABLET;ORAL ERLOTINIB HYDROCHLORIDE >D> @ TEVA PHARMS USA EQ 100MG BASE A 091059 002 Aug 28, 2015 Mar CMFD >A> AB EQ 100MG BASE A 091059 002 Aug 28, 2015 Mar CMFD >D> @ EQ 150MG BASE A 091059 003 Aug 28, 2015 Mar CMFD >A> AB EQ 150MG BASE A 091059 003 Aug 28, 2015 Mar CMFD TARCEVA >D> AB + OSI PHARMS EQ 25MG BASE N 021743 001 Nov 18, 2004 Mar CAHN >A> AB + EQ 25MG BASE N 021743 001 Nov 18, 2004 Mar CAHN >D> AB + EQ 100MG BASE N 021743 002 Nov 18, 2004 Mar CAHN >A> AB + EQ 100MG BASE N 021743 002 Nov 18, 2004 Mar CAHN >D> AB +! EQ 150MG BASE N 021743 003 Nov 18, 2004 Mar CAHN >A> AB +! EQ 150MG BASE N 021743 003 Nov 18, 2004 Mar CAHN

Page 10 of 30 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

ERTAPENEM SODIUM INJECTABLE;INTRAMUSCULAR, INTRAVENOUS ERTAPENEM SODIUM >A> AP SAVIOR LIFETEC CORP EQ 1GM BASE/VIAL A 207647 001 Mar 19, 2019 Mar NEWA

>A> ESKETAMINE HYDROCHLORIDE >A> SPRAY;NASAL >A> SPRAVATO >A> +! JANSSEN PHARMS EQ 28MG BASE N 211243 001 Mar 05, 2019 Mar NEWA

ESMOLOL HYDROCHLORIDE INJECTABLE;INJECTION ESMOLOL HYDROCHLORIDE >D> AP LUITPOLD 10MG/ML A 201126 001 Feb 20, 2015 Mar DISC >A> @ 10MG/ML A 201126 001 Feb 20, 2015 Mar DISC

ESOMEPRAZOLE MAGNESIUM CAPSULE, DELAYED REL PELLETS;ORAL ESOMEPRAZOLE MAGNESIUM >A> AB AMNEAL PHARMS NY EQ 20MG BASE A 209647 001 Apr 10, 2019 Mar NEWA >A> AB EQ 40MG BASE A 209647 002 Apr 10, 2019 Mar NEWA >D> AB HEC PHARM EQ 20MG BASE A 207265 002 May 18, 2018 Mar DISC >A> @ EQ 20MG BASE A 207265 002 May 18, 2018 Mar DISC >D> AB EQ 40MG BASE A 207265 001 May 18, 2018 Mar DISC >A> @ EQ 40MG BASE A 207265 001 May 18, 2018 Mar DISC

ESTRADIOL; NORETHINDRONE ACETATE TABLET;ORAL ESTRADIOL AND NORETHINDRONE ACETATE >D> AB ACCORD HLTHCARE 1MG;0.5MG A 210233 001 Feb 28, 2018 Mar DISC >A> @ 1MG;0.5MG A 210233 001 Feb 28, 2018 Mar DISC >A> AB NOVAST LABS 0.5MG;0.1MG A 210612 001 Apr 03, 2019 Mar NEWA >A> AB 1MG;0.5MG A 210612 002 Apr 03, 2019 Mar NEWA

ETHACRYNATE SODIUM INJECTABLE;INJECTION EDECRIN >A> AP +! BAUSCH EQ 50MG BASE/VIAL N 016093 001 Jan 10, 1967 Mar CAHN >D> AP +! VALEANT PHARMS INTL EQ 50MG BASE/VIAL N 016093 001 Jan 10, 1967 Mar CAHN

ETHACRYNIC ACID TABLET;ORAL EDECRIN >A> AB +! BAUSCH 25MG N 016092 001 Jan 10, 1967 Mar CAHN >A> @ 50MG N 016092 002 Jan 10, 1967 Mar CAHN >D> AB +! VALEANT PHARMS INTL 25MG N 016092 001 Jan 10, 1967 Mar CAHN >D> @ 50MG N 016092 002 Jan 10, 1967 Mar CAHN

ETHINYL ESTRADIOL; NORETHINDRONE TABLET, CHEWABLE;ORAL >D> FEMCON FE >D> AB +! APIL 0.035MG;0.4MG N 021490 001 Nov 14, 2003 Mar DISC >A> + @ 0.035MG;0.4MG N 021490 001 Nov 14, 2003 Mar DISC NORETHINDRONE AND ETHINYL ESTRADIOL AND FERROUS FUMARATE >D> AB MYLAN LABS LTD 0.035MG;0.4MG A 202086 001 Apr 01, 2015 Mar CHRS >A> AB ! 0.035MG;0.4MG A 202086 001 Apr 01, 2015 Mar CHRS TABLET;ORAL-28 NORTREL 1/35-28 >D> AB BARR 0.035MG;1MG A 072696 001 Feb 28, 1992 Mar CHRS >A> AB ! 0.035MG;1MG A 072696 001 Feb 28, 1992 Mar CHRS >D> ORTHO-NOVUM 1/35-28 >D> AB +! JANSSEN PHARMS 0.035MG;1MG N 017919 002 Jun 23, 1977 Mar DISC >A> + @ 0.035MG;1MG N 017919 002 Jun 23, 1977 Mar DISC

EVEROLIMUS TABLET;ORAL ZORTRESS >A> + NOVARTIS 1MG N 021560 004 Aug 10, 2018 Mar NEWA

Page 11 of 30 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

FENOFIBRATE TABLET;ORAL FENOGLIDE >A> AB + SALIX 40MG N 022118 001 Aug 10, 2007 Mar CAHN >A> AB +! 120MG N 022118 002 Aug 10, 2007 Mar CAHN >D> AB + SANTARUS INC 40MG N 022118 001 Aug 10, 2007 Mar CAHN >D> AB +! 120MG N 022118 002 Aug 10, 2007 Mar CAHN

FLOXURIDINE INJECTABLE;INJECTION FLOXURIDINE >D> AP LUITPOLD 500MG/VIAL A 203008 001 Nov 22, 2017 Mar DISC >A> @ 500MG/VIAL A 203008 001 Nov 22, 2017 Mar DISC

FLUOCINOLONE ACETONIDE SOLUTION;TOPICAL FLUOCINOLONE ACETONIDE >D> AT ACTAVIS LABS UT INC 0.01% A 208386 001 Oct 21, 2016 Mar DISC >A> @ 0.01% A 208386 001 Oct 21, 2016 Mar DISC

FLUOCINONIDE CREAM;TOPICAL FLUOCINONIDE >A> AB TELIGENT PHARMA INC 0.1% A 211758 001 Apr 03, 2019 Mar NEWA SOLUTION;TOPICAL FLUOCINONIDE >A> AT TELIGENT PHARMA INC 0.05% A 207554 001 Mar 18, 2019 Mar NEWA

FLUOXETINE HYDROCHLORIDE CAPSULE;ORAL FLUOXETINE HYDROCHLORIDE >D> AB PAR PHARM EQ 40MG BASE A 076922 003 Dec 16, 2004 Mar DISC >A> @ EQ 40MG BASE A 076922 003 Dec 16, 2004 Mar DISC TABLET;ORAL FLUOXETINE HYDROCHLORIDE >A> AB SCIEGEN PHARMS INC EQ 10MG BASE A 210935 001 Mar 20, 2019 Mar NEWA >A> AB EQ 20MG BASE A 210935 002 Mar 20, 2019 Mar NEWA

GABAPENTIN TABLET;ORAL GABAPENTIN >D> AB LUPIN LTD 600MG A 209306 001 Aug 24, 2018 Mar DISC >A> @ 600MG A 209306 001 Aug 24, 2018 Mar DISC >D> AB 800MG A 209306 002 Aug 24, 2018 Mar DISC >A> @ 800MG A 209306 002 Aug 24, 2018 Mar DISC

GANIRELIX ACETATE INJECTABLE;INJECTION GANIRELIX ACETATE >D> AP +! ORGANON USA INC EQ 250MCG BASE/0.5ML N 021057 001 Jul 29, 1999 Mar CPOT >A> AP +! 250MCG/0.5ML N 021057 001 Jul 29, 1999 Mar CPOT >A> AP SUN PHARM 250MCG/0.5ML A 204246 001 Nov 30, 2018 Mar CPOT >D> AP SUN PHARM INDS LTD EQ 250MCG BASE/0.5ML A 204246 001 Nov 30, 2018 Mar CPOT

GLIMEPIRIDE TABLET;ORAL GLIMEPIRIDE >A> AB MICRO LABS 1MG A 091220 001 Jun 29, 2012 Mar CAHN >A> AB 2MG A 091220 002 Jun 29, 2012 Mar CAHN >A> 3MG A 091220 003 Jun 29, 2012 Mar CAHN >A> AB 4MG A 091220 004 Jun 29, 2012 Mar CAHN >A> 6MG A 091220 005 Jun 29, 2012 Mar CAHN >A> AB 8MG A 091220 006 Jun 29, 2012 Mar CAHN >D> AB VIVA HLTHCARE 1MG A 091220 001 Jun 29, 2012 Mar CAHN >D> AB 2MG A 091220 002 Jun 29, 2012 Mar CAHN >D> 3MG A 091220 003 Jun 29, 2012 Mar CAHN >D> AB 4MG A 091220 004 Jun 29, 2012 Mar CAHN >D> 6MG A 091220 005 Jun 29, 2012 Mar CAHN >D> AB 8MG A 091220 006 Jun 29, 2012 Mar CAHN

Page 12 of 30 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

GLYCOPYRROLATE INJECTABLE;INJECTION GLYCOPYRROLATE >A> AP CAPLIN 0.2MG/ML A 211705 001 Mar 20, 2019 Mar NEWA TABLET;ORAL GLYCOPYRROLATE >D> AA BOSCOGEN 1MG A 091182 001 Feb 03, 2014 Mar CAHN >D> AA 2MG A 091182 002 Feb 03, 2014 Mar CAHN >A> AA KENTON 1MG A 091182 001 Feb 03, 2014 Mar CAHN >A> AA 2MG A 091182 002 Feb 03, 2014 Mar CAHN

HALOPERIDOL TABLET;ORAL HALOPERIDOL >D> @ ANDA REPOSITORY 0.5MG A 071156 001 Jan 02, 1987 Mar CAHN >D> @ 1MG A 071157 001 Jan 02, 1987 Mar CAHN >D> @ 2MG A 071172 001 Jan 02, 1987 Mar CAHN >D> @ 5MG A 071212 001 Jan 07, 1988 Mar CAHN >D> @ 10MG A 071173 001 Jan 07, 1988 Mar CAHN >D> @ 20MG A 071177 001 Jan 07, 1988 Mar CAHN >A> @ INNOGENIX 0.5MG A 071156 001 Jan 02, 1987 Mar CAHN >A> @ 1MG A 071157 001 Jan 02, 1987 Mar CAHN >A> @ 2MG A 071172 001 Jan 02, 1987 Mar CAHN >A> @ 5MG A 071212 001 Jan 07, 1988 Mar CAHN >A> @ 10MG A 071173 001 Jan 07, 1988 Mar CAHN >A> @ 20MG A 071177 001 Jan 07, 1988 Mar CAHN

HYDROCHLOROTHIAZIDE; VALSARTAN TABLET;ORAL VALSARTAN AND HYDROCHLOROTHIAZIDE >A> AB ZYDUS PHARMS 12.5MG;80MG A 203000 001 Mar 15, 2019 Mar NEWA >A> AB 12.5MG;160MG A 203000 002 Mar 15, 2019 Mar NEWA >A> AB 12.5MG;320MG A 203000 003 Mar 15, 2019 Mar NEWA >A> AB 25MG;160MG A 203000 004 Mar 15, 2019 Mar NEWA >A> AB 25MG;320MG A 203000 005 Mar 15, 2019 Mar NEWA

HYDROMORPHONE HYDROCHLORIDE TABLET, EXTENDED RELEASE;ORAL EXALGO >D> AB + SPECGX LLC 8MG N 021217 001 Mar 01, 2010 Mar DISC >A> + @ 8MG N 021217 001 Mar 01, 2010 Mar DISC >D> AB + 12MG N 021217 002 Mar 01, 2010 Mar DISC >A> + @ 12MG N 021217 002 Mar 01, 2010 Mar DISC >D> AB + 16MG N 021217 003 Mar 01, 2010 Mar DISC >A> + @ 16MG N 021217 003 Mar 01, 2010 Mar DISC >D> AB +! 32MG N 021217 004 Aug 24, 2012 Mar DISC >A> + @ 32MG N 021217 004 Aug 24, 2012 Mar DISC HYDROMORPHONE HYDROCHLORIDE >D> AB OSMOTICA 32MG A 205629 004 Jul 07, 2016 Mar CHRS >A> AB ! 32MG A 205629 004 Jul 07, 2016 Mar CHRS

HYDROXYPROGESTERONE CAPROATE SOLUTION;INTRAMUSCULAR HYDROXYPROGESTERONE CAPROATE >A> AP SLAYBACK PHARMA LLC 250MG/ML (250MG/ML) A 210877 001 Mar 22, 2019 Mar NEWA >A> AP SUN PHARM 1250MG/5ML (250MG/ML) A 208381 001 Apr 09, 2019 Mar NEWA

HYDROXYZINE HYDROCHLORIDE INJECTABLE;INJECTION HYDROXYZINE HYDROCHLORIDE >D> @ LUITPOLD 50MG/ML A 087408 002 Aug 27, 1981 Mar CMFD >A> ! 50MG/ML A 087408 002 Aug 27, 1981 Mar CMFD

IBUPROFEN TABLET;ORAL IBUPROFEN >D> AB HEC PHARM 400MG A 204062 001 Sep 10, 2018 Mar DISC >A> @ 400MG A 204062 001 Sep 10, 2018 Mar DISC >D> AB 600MG A 204062 002 Sep 10, 2018 Mar DISC >A> @ 600MG A 204062 002 Sep 10, 2018 Mar DISC

Page 13 of 30 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

IBUPROFEN TABLET;ORAL IBUPROFEN >D> AB 800MG A 204062 003 Sep 10, 2018 Mar DISC >A> @ 800MG A 204062 003 Sep 10, 2018 Mar DISC

IMIPRAMINE HYDROCHLORIDE TABLET;ORAL HYDROCHLORIDE >D> OXFORD PHARMS 10MG A 040751 003 Feb 28, 2008 Mar DISC >A> @ 10MG A 040751 003 Feb 28, 2008 Mar DISC >D> 25MG A 040751 002 Feb 28, 2008 Mar DISC >A> @ 25MG A 040751 002 Feb 28, 2008 Mar DISC

IPRATROPIUM BROMIDE SPRAY, METERED;NASAL >D> AB MYLAN SPECIALITY LP 0.021MG/SPRAY A 075552 001 Mar 31, 2003 Mar DISC >A> @ 0.021MG/SPRAY A 075552 001 Mar 31, 2003 Mar DISC >D> AB 0.042MG/SPRAY A 075553 001 Mar 31, 2003 Mar DISC >A> @ 0.042MG/SPRAY A 075553 001 Mar 31, 2003 Mar DISC

IRON DEXTRAN INJECTABLE;INJECTION DEXFERRUM >D> BP LUITPOLD EQ 50MG IRON/ML N 040024 001 Feb 23, 1996 Mar DISC >A> @ EQ 50MG IRON/ML N 040024 001 Feb 23, 1996 Mar DISC >D> PROFERDEX >D> BP NEW RIVER EQ 50MG IRON/ML N 017807 001 Mar 26, 1981 Mar DISC >A> @ EQ 50MG IRON/ML N 017807 001 Mar 26, 1981 Mar DISC

ISOPROTERENOL HYDROCHLORIDE INJECTABLE;INJECTION ISUPREL >A> AP +! BAUSCH 0.2MG/ML N 010515 001 May 25, 1956 Mar CAHN >D> AP +! VALEANT PHARMS NORTH 0.2MG/ML N 010515 001 May 25, 1956 Mar CAHN

ISOSORBIDE DINITRATE TABLET;ORAL ISORDIL >A> AB + BAUSCH 5MG N 012093 007 Jul 29, 1988 Mar CAHN >A> + @ 10MG N 012093 002 Jul 29, 1988 Mar CAHN >A> + @ 20MG N 012093 006 Jul 29, 1988 Mar CAHN >A> + @ 30MG N 012093 005 Jul 29, 1988 Mar CAHN >A> +! 40MG N 012093 001 Jul 29, 1988 Mar CAHN >D> AB + VALEANT PHARMS NORTH 5MG N 012093 007 Jul 29, 1988 Mar CAHN >D> + @ 10MG N 012093 002 Jul 29, 1988 Mar CAHN >D> + @ 20MG N 012093 006 Jul 29, 1988 Mar CAHN >D> + @ 30MG N 012093 005 Jul 29, 1988 Mar CAHN >D> +! 40MG N 012093 001 Jul 29, 1988 Mar CAHN

ISOSORBIDE MONONITRATE TABLET, EXTENDED RELEASE;ORAL ISOSORBIDE MONONITRATE >A> AB HIKMA INTL PHARMS 30MG A 076813 002 Mar 30, 2006 Mar CAHN >A> AB 60MG A 076813 001 Jan 07, 2005 Mar CAHN >D> AB HIKMA PHARMS 30MG A 076813 002 Mar 30, 2006 Mar CAHN >D> AB 60MG A 076813 001 Jan 07, 2005 Mar CAHN

KETOROLAC TROMETHAMINE SOLUTION/DROPS;OPHTHALMIC KETOROLAC TROMETHAMINE >A> AT MICRO LABS LTD INDIA 0.5% A 203410 001 Apr 05, 2019 Mar NEWA

LACTULOSE SOLUTION;ORAL LACTULOSE >D> @ BAJAJ 10GM/15ML A 075911 001 Feb 21, 2002 Mar CAHN >A> @ XTTRIUM LABS INC 10GM/15ML A 075911 001 Feb 21, 2002 Mar CAHN

Page 14 of 30 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

LAMIVUDINE TABLET;ORAL LAMIVUDINE >A> AB ANNORA 100MG A 211306 001 Mar 21, 2019 Mar NEWA

LAMOTRIGINE TABLET, EXTENDED RELEASE;ORAL LAMOTRIGINE >D> @ HANDA PHARMS LLC 25MG A 202887 001 Jun 17, 2013 Mar CAHN >D> @ 50MG A 202887 002 Jun 17, 2013 Mar CAHN >D> AB 100MG A 202887 003 Jun 17, 2013 Mar CAHN >D> AB 200MG A 202887 004 Jun 17, 2013 Mar CAHN >A> @ RUBICON 25MG A 202887 001 Jun 17, 2013 Mar CAHN >A> @ 50MG A 202887 002 Jun 17, 2013 Mar CAHN >A> AB 100MG A 202887 003 Jun 17, 2013 Mar CAHN >A> AB 200MG A 202887 004 Jun 17, 2013 Mar CAHN

>A> LATANOPROST; NETARSUDIL DIMESYLATE >A> SOLUTION/DROPS;OPHTHALMIC >A> ROCKLATAN >A> +! AERIE PHARMS INC 0.005%;EQ 0.02% BASE N 208259 001 Mar 12, 2019 Mar NEWA

LEVETIRACETAM INJECTABLE;IV (INFUSION) >D> LEVETIRACETAM >D> AP LUITPOLD 500MG/5ML (100MG/ML) A 202143 001 Jan 31, 2012 Mar DISC >A> @ 500MG/5ML (100MG/ML) A 202143 001 Jan 31, 2012 Mar DISC

LEVOCETIRIZINE DIHYDROCHLORIDE SOLUTION;ORAL LEVOCETIRIZINE HYDROCHLORIDE >A> AA HETERO LABS LTD III 2.5MG/5ML A 210914 001 Apr 01, 2019 Mar NEWA

LEVOLEUCOVORIN POWDER;INTRAVENOUS KHAPZORY >A> +! ACROTECH 175MG/VIAL N 211226 001 Oct 19, 2018 Mar CAHN >A> +! 300MG/VIAL N 211226 002 Oct 19, 2018 Mar CAHN >D> +! SPECTRUM PHARMS 175MG/VIAL N 211226 001 Oct 19, 2018 Mar CAHN >D> +! 300MG/VIAL N 211226 002 Oct 19, 2018 Mar CAHN

LEVOLEUCOVORIN CALCIUM POWDER;INTRAVENOUS FUSILEV >A> AP +! ACROTECH EQ 50MG BASE/VIAL N 020140 001 Mar 07, 2008 Mar CAHN >D> AP +! SPECTRUM PHARMS EQ 50MG BASE/VIAL N 020140 001 Mar 07, 2008 Mar CAHN SOLUTION;INTRAVENOUS FUSILEV >A> + @ ACROTECH EQ 175MG BASE/17.5ML (EQ 10MG N 020140 002 Apr 29, 2011 Mar CAHN BASE/ML) >A> + @ EQ 250MG BASE/25ML (EQ 10MG N 020140 003 Apr 29, 2011 Mar CAHN BASE/ML) >D> + @ SPECTRUM PHARMS EQ 175MG BASE/17.5ML (EQ 10MG N 020140 002 Apr 29, 2011 Mar CAHN BASE/ML) >D> + @ EQ 250MG BASE/25ML (EQ 10MG N 020140 003 Apr 29, 2011 Mar CAHN BASE/ML)

LEVOTHYROXINE SODIUM TABLET;ORAL THYRO-TABS >A> --> + ALVOGEN --> 0.025MG N 021116 001 Oct 24, 2002 Mar CAHN AB2,AB4 >A> --> + --> 0.05MG N 021116 002 Oct 24, 2002 Mar CAHN AB2,AB4 >A> --> + --> 0.075MG N 021116 003 Oct 24, 2002 Mar CAHN AB2,AB4 >A> --> + --> 0.088MG N 021116 010 Oct 24, 2002 Mar CAHN AB2,AB4 >A> --> + --> 0.1MG N 021116 004 Oct 24, 2002 Mar CAHN AB2,AB4 >A> --> + --> 0.112MG N 021116 011 Oct 24, 2002 Mar CAHN AB2,AB4 >A> --> + --> AB2, 0.125MG N 021116 005 Oct 24, 2002 Mar CAHN

Page 15 of 30 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

LEVOTHYROXINE SODIUM TABLET;ORAL THYRO-TABS AB4 >A> --> + --> 0.137MG N 021116 012 Dec 07, 2004 Mar CAHN AB2,AB4 >A> --> + --> 0.15MG N 021116 006 Oct 24, 2002 Mar CAHN AB2,AB4 >A> --> + --> 0.175MG N 021116 007 Oct 24, 2002 Mar CAHN AB2,AB4 >A> --> + --> 0.2MG N 021116 008 Oct 24, 2002 Mar CAHN AB2,AB4 >A> --> +! --> 0.3MG N 021116 009 Oct 24, 2002 Mar CAHN AB2,AB4 >D> --> + LLOYD --> 0.025MG N 021116 001 Oct 24, 2002 Mar CAHN AB2,AB4 >D> --> + --> 0.05MG N 021116 002 Oct 24, 2002 Mar CAHN AB2,AB4 >D> --> + --> 0.075MG N 021116 003 Oct 24, 2002 Mar CAHN AB2,AB4 >D> --> + --> 0.088MG N 021116 010 Oct 24, 2002 Mar CAHN AB2,AB4 >D> --> + --> 0.1MG N 021116 004 Oct 24, 2002 Mar CAHN AB2,AB4 >D> --> + --> 0.112MG N 021116 011 Oct 24, 2002 Mar CAHN AB2,AB4 >D> --> + --> 0.125MG N 021116 005 Oct 24, 2002 Mar CAHN AB2,AB4 >D> --> + --> 0.137MG N 021116 012 Dec 07, 2004 Mar CAHN AB2,AB4 >D> --> + --> 0.15MG N 021116 006 Oct 24, 2002 Mar CAHN AB2,AB4 >D> --> + --> 0.175MG N 021116 007 Oct 24, 2002 Mar CAHN AB2,AB4 >D> --> + --> 0.2MG N 021116 008 Oct 24, 2002 Mar CAHN AB2,AB4 >D> --> +! --> 0.3MG N 021116 009 Oct 24, 2002 Mar CAHN AB2,AB4

LIDOCAINE HYDROCHLORIDE INJECTABLE;INJECTION LIDOCAINE HYDROCHLORIDE >D> AP LUITPOLD 1% A 080850 001 Jun 23, 1972 Mar DISC >A> @ 1% A 080850 001 Jun 23, 1972 Mar DISC

LIOTHYRONINE SODIUM TABLET;ORAL LIOTHYRONINE SODIUM >D> AB MYLAN EQ 0.005MG BASE A 090326 001 Jul 14, 2009 Mar DISC >A> @ EQ 0.005MG BASE A 090326 001 Jul 14, 2009 Mar DISC >D> AB EQ 0.025MG BASE A 090326 002 Jul 14, 2009 Mar DISC >A> @ EQ 0.025MG BASE A 090326 002 Jul 14, 2009 Mar DISC >D> AB EQ 0.05MG BASE A 090326 003 Jul 14, 2009 Mar DISC >A> @ EQ 0.05MG BASE A 090326 003 Jul 14, 2009 Mar DISC

LORAZEPAM INJECTABLE;INJECTION ATIVAN >A> AP +! HIKMA 2MG/ML N 018140 001 Jul 25, 1980 Mar CAHN >A> AP +! 4MG/ML N 018140 002 Jul 25, 1980 Mar CAHN >D> AP +! WEST-WARD PHARMS INT 2MG/ML N 018140 001 Jul 25, 1980 Mar CAHN >D> AP +! 4MG/ML N 018140 002 Jul 25, 1980 Mar CAHN

LOSARTAN POTASSIUM TABLET;ORAL LOSARTAN POTASSIUM >A> AB HISUN PHARM HANGZHOU 25MG A 204795 001 Apr 04, 2019 Mar NEWA >A> AB 50MG A 204795 002 Apr 04, 2019 Mar NEWA >A> AB 100MG A 204795 003 Apr 04, 2019 Mar NEWA >A> AB MICRO LABS 25MG A 091541 001 Sep 24, 2012 Mar CAHN >A> AB 50MG A 091541 002 Sep 24, 2012 Mar CAHN >A> AB 100MG A 091541 003 Sep 24, 2012 Mar CAHN >D> AB VIVA HLTHCARE 25MG A 091541 001 Sep 24, 2012 Mar CAHN >D> AB 50MG A 091541 002 Sep 24, 2012 Mar CAHN

Page 16 of 30 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

LOSARTAN POTASSIUM TABLET;ORAL LOSARTAN POTASSIUM >D> AB 100MG A 091541 003 Sep 24, 2012 Mar CAHN

LURASIDONE HYDROCHLORIDE TABLET;ORAL LURASIDONE HYDROCHLORIDE >A> AB ZYDUS PHARMS 20MG A 208052 001 Mar 19, 2019 Mar NEWA >A> AB 40MG A 208052 002 Mar 19, 2019 Mar NEWA >A> AB 60MG A 208052 003 Mar 19, 2019 Mar NEWA >A> AB 80MG A 208052 004 Mar 19, 2019 Mar NEWA >A> AB 120MG A 208052 005 Mar 19, 2019 Mar NEWA

MAGNESIUM SULFATE; POTASSIUM SULFATE; SODIUM SULFATE >D> POWDER;ORAL >D> COLPREP KIT >D> +! GATOR PHARMS 1.6GM/BOT;3.13GM/BOT;17.5GM/BOT N 204553 001 Dec 27, 2016 Mar DISC >A> + @ 1.6GM/BOT;3.13GM/BOT;17.5GM/BOT N 204553 001 Dec 27, 2016 Mar DISC

MANNITOL INJECTABLE;INJECTION MANNITOL 25% >D> AP LUITPOLD 12.5GM/50ML A 087409 001 Jan 21, 1982 Mar DISC >A> @ 12.5GM/50ML A 087409 001 Jan 21, 1982 Mar DISC

MELPHALAN HYDROCHLORIDE POWDER;INTRAVENOUS EVOMELA >A> +! ACROTECH EQ 50MG BASE/VIAL N 207155 001 Mar 10, 2016 Mar CAHN >D> +! SPECTRUM PHARMS EQ 50MG BASE/VIAL N 207155 001 Mar 10, 2016 Mar CAHN

METFORMIN HYDROCHLORIDE TABLET, EXTENDED RELEASE;ORAL METFORMIN HYDROCHLORIDE >D> AB1 YICHANG HUMANWELL 500MG A 211052 001 Sep 24, 2018 Mar DISC >A> @ 500MG A 211052 001 Sep 24, 2018 Mar DISC >D> AB 750MG A 211052 002 Sep 24, 2018 Mar DISC >A> @ 750MG A 211052 002 Sep 24, 2018 Mar DISC

METFORMIN HYDROCHLORIDE; PIOGLITAZONE HYDROCHLORIDE TABLET, EXTENDED RELEASE;ORAL ACTOPLUS MET XR >D> + TAKEDA PHARMS USA 1GM;EQ 15MG BASE N 022024 001 May 12, 2009 Mar DISC >A> + @ 1GM;EQ 15MG BASE N 022024 001 May 12, 2009 Mar DISC >D> +! 1GM;EQ 30MG BASE N 022024 002 May 12, 2009 Mar DISC >A> + @ 1GM;EQ 30MG BASE N 022024 002 May 12, 2009 Mar DISC

METHAZOLAMIDE TABLET;ORAL METHAZOLAMIDE >D> AB MICRO LABS 25MG A 207438 001 Oct 05, 2018 Mar DISC >A> @ 25MG A 207438 001 Oct 05, 2018 Mar DISC >D> AB 50MG A 207438 002 Oct 05, 2018 Mar DISC >A> @ 50MG A 207438 002 Oct 05, 2018 Mar DISC

METHYLDOPATE HYDROCHLORIDE INJECTABLE;INJECTION METHYLDOPATE HYDROCHLORIDE >D> ! LUITPOLD 50MG/ML A 071279 001 Oct 02, 1987 Mar DISC >A> @ 50MG/ML A 071279 001 Oct 02, 1987 Mar DISC

METHYLERGONOVINE MALEATE TABLET;ORAL METHYLERGONOVINE MALEATE >A> AB TEVA PHARMS USA 0.2MG A 211455 001 Mar 20, 2019 Mar NEWA

Page 17 of 30 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

METHYLPHENIDATE HYDROCHLORIDE CAPSULE, EXTENDED RELEASE;ORAL ADHANSIA XR >D> PURDUE PHARMA LP 25MG N 212038 001 Feb 27, 2019 Mar CRLD >A> + 25MG N 212038 001 Feb 27, 2019 Mar CRLD

METHYLPREDNISOLONE TABLET;ORAL MEDROL >D> + PHARMACIA AND UPJOHN 2MG N 011153 002 Mar 03, 1958 Mar CFTG >A> AB + 2MG N 011153 002 Mar 03, 1958 Mar CFTG METHYLPREDNISOLONE >D> AB LUPIN LTD 2MG A 209097 001 Feb 22, 2019 Mar NFTG >A> AB 2MG A 209097 001 Feb 22, 2019 Mar NFTG

METHYLPREDNISOLONE SODIUM SUCCINATE INJECTABLE;INJECTION >D> A-METHAPRED >D> AP HOSPIRA EQ 40MG BASE/VIAL A 040664 001 Dec 20, 2005 Mar DISC >A> @ EQ 40MG BASE/VIAL A 040664 001 Dec 20, 2005 Mar DISC >D> AP EQ 125MG BASE/VIAL A 040665 001 Dec 20, 2005 Mar DISC >A> @ EQ 125MG BASE/VIAL A 040665 001 Dec 20, 2005 Mar DISC

METOPROLOL SUCCINATE TABLET, EXTENDED RELEASE;ORAL TOPROL-XL >D> AB + ARALEZ PHARMS EQ 25MG TARTRATE N 019962 004 Feb 05, 2001 Mar CAHN >D> AB +! EQ 50MG TARTRATE N 019962 001 Jan 10, 1992 Mar CAHN >D> AB + EQ 100MG TARTRATE N 019962 002 Jan 10, 1992 Mar CAHN >D> AB +! EQ 200MG TARTRATE N 019962 003 Jan 10, 1992 Mar CAHN >A> AB + TOPROL EQ 25MG TARTRATE N 019962 004 Feb 05, 2001 Mar CAHN >A> AB +! EQ 50MG TARTRATE N 019962 001 Jan 10, 1992 Mar CAHN >A> AB + EQ 100MG TARTRATE N 019962 002 Jan 10, 1992 Mar CAHN >A> AB +! EQ 200MG TARTRATE N 019962 003 Jan 10, 1992 Mar CAHN

METOPROLOL TARTRATE INJECTABLE;INJECTION METOPROLOL TARTRATE >D> AP LUITPOLD 1MG/ML A 090386 001 Sep 30, 2009 Mar DISC >A> @ 1MG/ML A 090386 001 Sep 30, 2009 Mar DISC

METRONIDAZOLE GEL;VAGINAL METROGEL-VAGINAL >A> AB +! BAUSCH 0.75% N 020208 001 Aug 17, 1992 Mar CAHN >D> AB +! MEDICIS 0.75% N 020208 001 Aug 17, 1992 Mar CAHN TABLET;ORAL METRONIDAZOLE >A> AB CADILA 250MG A 206560 001 Nov 16, 2016 Mar CAHN >A> AB 500MG A 206560 002 Nov 16, 2016 Mar CAHN >D> AB ZYDUS PHARMS 250MG A 206560 001 Nov 16, 2016 Mar CAHN >D> AB 500MG A 206560 002 Nov 16, 2016 Mar CAHN

METYROSINE CAPSULE;ORAL DEMSER >D> +! ATON PHARMA VPNA 250MG N 017871 001 Oct 03, 1979 Mar CAHN >A> +! BAUSCH 250MG N 017871 001 Oct 03, 1979 Mar CAHN

MIFEPRISTONE TABLET;ORAL MIFEPREX >D> +! DANCO LABS LLC 200MG N 020687 001 Sep 28, 2000 Mar CFTG >A> AB +! 200MG N 020687 001 Sep 28, 2000 Mar CFTG >A> MIFEPRISTONE >A> AB GENBIOPRO 200MG A 091178 001 Apr 11, 2019 Mar NFTG

Page 18 of 30 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

MITOXANTRONE HYDROCHLORIDE INJECTABLE;INJECTION MITOXANTRONE HYDROCHLORIDE >D> AP MYLAN INSTITUTIONAL EQ 20MG BASE/10ML (EQ 2MG A 078980 001 Apr 13, 2009 Mar DISC BASE/ML) >A> @ EQ 20MG BASE/10ML (EQ 2MG A 078980 001 Apr 13, 2009 Mar DISC BASE/ML) >D> AP EQ 30MG BASE/15ML (EQ 2MG A 078980 002 Apr 13, 2009 Mar DISC BASE/ML) >A> @ EQ 30MG BASE/15ML (EQ 2MG A 078980 002 Apr 13, 2009 Mar DISC BASE/ML)

MONTELUKAST SODIUM GRANULE;ORAL SODIUM >A> AB TORRENT EQ 4MG BASE/PACKET A 210431 001 Jul 31, 2018 Mar CAHN >D> AB TORRENT PHARMS LLC EQ 4MG BASE/PACKET A 210431 001 Jul 31, 2018 Mar CAHN

MORPHINE SULFATE INJECTABLE;INJECTION ASTRAMORPH PF >D> AP FRESENIUS KABI USA 0.5MG/ML A 071050 001 Oct 07, 1986 Mar DISC >A> @ 0.5MG/ML A 071050 001 Oct 07, 1986 Mar DISC >D> AP 0.5MG/ML A 071051 001 Oct 07, 1986 Mar DISC >A> @ 0.5MG/ML A 071051 001 Oct 07, 1986 Mar DISC >D> AP 1MG/ML A 071052 001 Oct 07, 1986 Mar DISC >A> @ 1MG/ML A 071052 001 Oct 07, 1986 Mar DISC >D> AP 1MG/ML A 071053 001 Oct 07, 1986 Mar DISC >A> @ 1MG/ML A 071053 001 Oct 07, 1986 Mar DISC TABLET, EXTENDED RELEASE;ORAL ARYMO ER >D> + @ EGALET 15MG N 208603 001 Jan 09, 2017 Mar CAHN >A> + @ 15MG N 208603 001 Jan 09, 2017 Mar CAHN >D> + @ 30MG N 208603 002 Jan 09, 2017 Mar CAHN >A> + @ 30MG N 208603 002 Jan 09, 2017 Mar CAHN >D> + @ 60MG N 208603 003 Jan 09, 2017 Mar CAHN >A> + @ 60MG N 208603 003 Jan 09, 2017 Mar CAHN

MOXIFLOXACIN HYDROCHLORIDE TABLET;ORAL MOXIFLOXACIN HYDROCHLORIDE >D> AB SUNSHINE LAKE EQ 400MG BASE A 206295 001 Sep 28, 2018 Mar DISC >A> @ EQ 400MG BASE A 206295 001 Sep 28, 2018 Mar DISC

NAFTIFINE HYDROCHLORIDE GEL;TOPICAL NAFTIFINE HYDROCHLORIDE >A> AB TARO 2% A 208201 001 Apr 10, 2019 Mar NFTG >A> AB TOLMAR 1% A 206165 001 Mar 20, 2019 Mar NFTG NAFTIN >D> +! SEBELA IRELAND LTD 1% N 019356 001 Jun 18, 1990 Mar CFTG >A> AB +! 1% N 019356 001 Jun 18, 1990 Mar CFTG >D> +! 2% N 204286 001 Jun 27, 2013 Mar CFTG >A> AB +! 2% N 204286 001 Jun 27, 2013 Mar CFTG

NORETHINDRONE TABLET;ORAL-28 >D> MICRONOR >D> AB2 +! JANSSEN PHARMS 0.35MG N 016954 001 Jan 02, 1973 Mar DISC >A> + @ 0.35MG N 016954 001 Jan 02, 1973 Mar DISC NORETHINDRONE >D> AB2 MYLAN LABS LTD 0.35MG A 200980 001 Jun 12, 2013 Mar CHRS >A> AB2 ! 0.35MG A 200980 001 Jun 12, 2013 Mar CHRS

NYSTATIN; ACETONIDE OINTMENT;TOPICAL NYSTATIN AND TRIAMCINOLONE ACETONIDE >A> @ ZYDUS PHARMS 100,000 UNITS/GM;0.1% A 207764 001 Nov 08, 2018 Mar DISC >D> AT ZYDUS PHARMS USA INC 100,000 UNITS/GM;0.1% A 207764 001 Nov 08, 2018 Mar DISC

Page 19 of 30 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

OCTREOTIDE ACETATE INJECTABLE;INJECTION OCTREOTIDE ACETATE >D> AP HERITAGE PHARMS INC EQ 0.2MG BASE/ML A 203765 001 Sep 07, 2018 Mar DISC >A> @ EQ 0.2MG BASE/ML A 203765 001 Sep 07, 2018 Mar DISC >D> AP EQ 1MG BASE/ML A 203765 002 Sep 07, 2018 Mar DISC >A> @ EQ 1MG BASE/ML A 203765 002 Sep 07, 2018 Mar DISC

OFLOXACIN SOLUTION/DROPS;OPHTHALMIC OFLOXACIN >D> AT SANDOZ INC 0.3% A 076231 001 May 14, 2004 Mar DISC >A> @ 0.3% A 076231 001 May 14, 2004 Mar DISC SOLUTION/DROPS;OTIC OFLOXACIN >D> AT SANDOZ INC 0.3% A 078222 001 Mar 17, 2008 Mar DISC >A> @ 0.3% A 078222 001 Mar 17, 2008 Mar DISC

OLOPATADINE HYDROCHLORIDE SOLUTION/DROPS;OPHTHALMIC HYDROCHLORIDE >A> AT AUROBINDO PHARMA LTD EQ 0.2% BASE A 209995 001 Apr 04, 2019 Mar NEWA

OXAPROZIN TABLET;ORAL OXAPROZIN >A> @ BEXIMCO PHARMS USA 600MG A 075842 001 Apr 12, 2001 Mar CAHN >D> @ SANDOZ 600MG A 075842 001 Apr 12, 2001 Mar CAHN

PACLITAXEL INJECTABLE;INJECTION PACLITAXEL >D> AP ACCORD HLTHCARE 6MG/ML A 205720 001 Aug 17, 2018 Mar DISC >A> @ 6MG/ML A 205720 001 Aug 17, 2018 Mar DISC

PALONOSETRON HYDROCHLORIDE INJECTABLE;INTRAVENOUS PALONOSETRON HYDROCHLORIDE >D> AP DR REDDYS LABS LTD EQ 0.075MG BASE/1.5ML (EQ A 201533 001 Apr 21, 2016 Mar DISC 0.05MG BASE/ML) >A> @ EQ 0.075MG BASE/1.5ML (EQ A 201533 001 Apr 21, 2016 Mar DISC 0.05MG BASE/ML)

PAMIDRONATE DISODIUM INJECTABLE;INJECTION PAMIDRONATE DISODIUM >D> AP LUITPOLD 30MG/10ML (3MG/ML) A 078942 001 Jul 25, 2008 Mar DISC >A> @ 30MG/10ML (3MG/ML) A 078942 001 Jul 25, 2008 Mar DISC >D> AP 90MG/10ML (9MG/ML) A 078942 002 Jul 25, 2008 Mar DISC >A> @ 90MG/10ML (9MG/ML) A 078942 002 Jul 25, 2008 Mar DISC

PENTOSTATIN INJECTABLE;INJECTION PENTOSTATIN >D> AP MYLAN INSTITUTIONAL 10MG/VIAL A 203554 001 Sep 19, 2014 Mar DISC >A> @ 10MG/VIAL A 203554 001 Sep 19, 2014 Mar DISC

PERMETHRIN CREAM;TOPICAL PERMETHRIN >A> AB ENCUBE ETHICALS 5% A 211303 001 Apr 03, 2019 Mar NEWA

PIRBUTEROL ACETATE AEROSOL, METERED;INHALATION MAXAIR >A> @ BAUSCH EQ 0.2MG BASE/INH N 019009 001 Dec 30, 1986 Mar CAHN >D> @ VALEANT PHARMS EQ 0.2MG BASE/INH N 019009 001 Dec 30, 1986 Mar CAHN

Page 20 of 30 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

PITAVASTATIN CALCIUM TABLET;ORAL PITAVASTATIN CALCIUM >A> AB MYLAN PHARMS INC EQ 1MG BASE A 206070 001 Apr 04, 2019 Mar NEWA >A> AB EQ 2MG BASE A 206070 002 Apr 04, 2019 Mar NEWA >A> AB EQ 4MG BASE A 206070 003 Apr 04, 2019 Mar NEWA

PLECANATIDE TABLET;ORAL TRULANCE >A> +! BAUSCH 3MG N 208745 001 Jan 19, 2017 Mar CAHN >D> +! SYNERGY PHARMS 3MG N 208745 001 Jan 19, 2017 Mar CAHN

POTASSIUM CHLORIDE SOLUTION;ORAL POTASSIUM CHLORIDE >A> AA PHARM ASSOC 20MEQ/15ML A 210766 001 Mar 29, 2019 Mar NEWA >A> AA 40MEQ/15ML A 210766 002 Mar 29, 2019 Mar NEWA TABLET, EXTENDED RELEASE;ORAL KLOR-CON M15 >D> UPSHER SMITH LABS 15MEQ A 074726 003 Jun 06, 2003 Mar CTEC >A> AB1 15MEQ A 074726 003 Jun 06, 2003 Mar CTEC POTASSIUM CHLORIDE >A> AB1 PII 10MEQ A 206630 001 Mar 29, 2019 Mar NEWA >A> AB1 15MEQ A 206630 002 Mar 29, 2019 Mar NEWA >A> AB1 20MEQ A 206630 003 Mar 29, 2019 Mar NEWA

PRALATREXATE SOLUTION;INTRAVENOUS FOLOTYN >A> + ACROTECH 20MG/ML (20MG/ML) N 022468 001 Sep 24, 2009 Mar CAHN >A> +! 40MG/2ML (20MG/ML) N 022468 002 Sep 24, 2009 Mar CAHN >D> + ALLOS 20MG/ML (20MG/ML) N 022468 001 Sep 24, 2009 Mar CAHN >D> +! 40MG/2ML (20MG/ML) N 022468 002 Sep 24, 2009 Mar CAHN

PROGESTERONE INJECTABLE;INJECTION PROGESTERONE >D> AO LUITPOLD 50MG/ML A 090845 001 Jun 22, 2009 Mar DISC >A> @ 50MG/ML A 090845 001 Jun 22, 2009 Mar DISC

PROMETHAZINE HYDROCHLORIDE TABLET;ORAL HYDROCHLORIDE >D> IMPAX LABS 12.5MG A 040791 002 Feb 12, 2008 Mar DISC >A> @ 12.5MG A 040791 002 Feb 12, 2008 Mar DISC >D> 25MG A 040791 003 Feb 12, 2008 Mar DISC >A> @ 25MG A 040791 003 Feb 12, 2008 Mar DISC

PROPRANOLOL HYDROCHLORIDE TABLET;ORAL PROPRANOLOL HYDROCHLORIDE >D> @ ANDA REPOSITORY 10MG A 070319 001 Oct 22, 1985 Mar CAHN >D> @ 20MG A 070320 001 Oct 22, 1985 Mar CAHN >D> @ 40MG A 070103 001 Oct 22, 1985 Mar CAHN >D> @ 60MG A 070321 001 Sep 24, 1986 Mar CAHN >D> @ 80MG A 070322 001 Aug 04, 1986 Mar CAHN >A> @ INNOGENIX 10MG A 070319 001 Oct 22, 1985 Mar CAHN >A> @ 10MG A 070319 001 Oct 22, 1985 Mar CAHN >A> @ 20MG A 070320 001 Oct 22, 1985 Mar CAHN >A> @ 40MG A 070103 001 Oct 22, 1985 Mar CAHN >A> @ 60MG A 070321 001 Sep 24, 1986 Mar CAHN >A> @ 60MG A 070321 001 Sep 24, 1986 Mar CAHN >A> @ 80MG A 070322 001 Aug 04, 1986 Mar CAHN

Page 21 of 30 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

QUININE SULFATE CAPSULE;ORAL QUININE SULFATE >D> AB MYLAN PHARMS INC 324MG A 202581 001 Dec 14, 2012 Mar DISC >A> @ 324MG A 202581 001 Dec 14, 2012 Mar DISC

RANITIDINE HYDROCHLORIDE CAPSULE;ORAL RANITIDINE HYDROCHLORIDE >A> AB APPCO PHARMA LLC EQ 150MG BASE A 211893 001 Apr 05, 2019 Mar NEWA >A> AB EQ 300MG BASE A 211893 002 Apr 05, 2019 Mar NEWA

RASAGILINE MESYLATE TABLET;ORAL RASAGILINE MESYLATE >A> AB MICRO LABS EQ 0.5MG BASE A 207004 001 Mar 29, 2019 Mar NEWA >A> AB EQ 1MG BASE A 207004 002 Mar 29, 2019 Mar NEWA

REPAGLINIDE TABLET;ORAL >D> PRANDIN >D> AB + GEMINI LABS LLC 0.5MG N 020741 001 Dec 22, 1997 Mar DISC >A> + @ 0.5MG N 020741 001 Dec 22, 1997 Mar DISC >D> AB + 1MG N 020741 002 Dec 22, 1997 Mar DISC >A> + @ 1MG N 020741 002 Dec 22, 1997 Mar DISC >D> AB +! 2MG N 020741 003 Dec 22, 1997 Mar DISC >A> + @ 2MG N 020741 003 Dec 22, 1997 Mar DISC REPAGLINIDE >D> AB AUROBINDO PHARMA LTD 2MG A 203820 003 Jan 22, 2014 Mar CHRS >A> AB ! 2MG A 203820 003 Jan 22, 2014 Mar CHRS

RETAPAMULIN OINTMENT;TOPICAL ALTABAX >A> +! ALMIRALL 1% N 022055 001 Apr 12, 2007 Mar CAHN >D> +! AQUA PHARMS LLC 1% N 022055 001 Apr 12, 2007 Mar CAHN

RILUZOLE TABLET;ORAL RILUZOLE >D> AB DAITO PHARMS CO LTD 50MG A 204430 001 Oct 16, 2018 Mar DISC >A> @ 50MG A 204430 001 Oct 16, 2018 Mar DISC

ROFLUMILAST TABLET;ORAL >A> AB MICRO LABS 500MCG A 208180 001 Mar 22, 2019 Mar NEWA

ROPINIROLE HYDROCHLORIDE TABLET;ORAL ROPINIROLE HYDROCHLORIDE >D> AB APOTEX EQ 0.25MG BASE A 079165 001 Feb 07, 2012 Mar CAHN >D> AB EQ 0.5MG BASE A 079165 002 Feb 07, 2012 Mar CAHN >D> AB EQ 1MG BASE A 079165 003 Feb 07, 2012 Mar CAHN >D> AB EQ 2MG BASE A 079165 004 Feb 07, 2012 Mar CAHN >D> AB EQ 3MG BASE A 079165 005 Feb 07, 2012 Mar CAHN >D> AB EQ 4MG BASE A 079165 006 Feb 07, 2012 Mar CAHN >D> AB EQ 5MG BASE A 079165 007 Feb 07, 2012 Mar CAHN >A> AB LAX EQ 0.25MG BASE A 079165 001 Feb 07, 2012 Mar CAHN >A> AB EQ 0.5MG BASE A 079165 002 Feb 07, 2012 Mar CAHN >A> AB EQ 1MG BASE A 079165 003 Feb 07, 2012 Mar CAHN >A> AB EQ 2MG BASE A 079165 004 Feb 07, 2012 Mar CAHN >A> AB EQ 3MG BASE A 079165 005 Feb 07, 2012 Mar CAHN >A> AB EQ 4MG BASE A 079165 006 Feb 07, 2012 Mar CAHN >A> AB EQ 5MG BASE A 079165 007 Feb 07, 2012 Mar CAHN

Page 22 of 30 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

ROSUVASTATIN CALCIUM TABLET;ORAL ROSUVASTATIN CALCIUM >A> AB UMEDICA LABS PVT LTD 5MG A 207626 001 Apr 09, 2019 Mar NEWA >A> AB 10MG A 207626 002 Apr 09, 2019 Mar NEWA >A> AB 20MG A 207626 003 Apr 09, 2019 Mar NEWA >A> AB 40MG A 207626 004 Apr 09, 2019 Mar NEWA

SELEGILINE HYDROCHLORIDE CAPSULE;ORAL SELEGILINE HYDROCHLORIDE >A> AB PACK PHARMS LLC 5MG A 206803 001 Apr 02, 2019 Mar NEWA TABLET, ORALLY DISINTEGRATING;ORAL ZELAPAR >A> +! BAUSCH 1.25MG N 021479 001 Jun 14, 2006 Mar CAHN >D> +! VALEANT PHARM INTL 1.25MG N 021479 001 Jun 14, 2006 Mar CAHN TABLET;ORAL SELEGILINE HYDROCHLORIDE >D> AB BOSCOGEN 5MG A 074912 001 Apr 30, 1998 Mar CAHN >A> AB KENTON 5MG A 074912 001 Apr 30, 1998 Mar CAHN

SILDENAFIL CITRATE TABLET;ORAL SILDENAFIL CITRATE >A> AB LUPIN LTD EQ 25MG BASE A 212051 001 Mar 22, 2019 Mar NEWA >A> AB EQ 50MG BASE A 212051 002 Mar 22, 2019 Mar NEWA >A> AB EQ 100MG BASE A 212051 003 Mar 22, 2019 Mar NEWA >A> AB MYLAN PHARMS INC EQ 25MG BASE A 201171 001 Mar 25, 2019 Mar NEWA >A> AB EQ 50MG BASE A 201171 002 Mar 25, 2019 Mar NEWA >A> AB EQ 100MG BASE A 201171 003 Mar 25, 2019 Mar NEWA

SIMVASTATIN TABLET;ORAL SIMVASTATIN >A> AB MICRO LABS 5MG A 090383 001 Sep 16, 2011 Mar CAHN >A> AB 10MG A 090383 002 Sep 16, 2011 Mar CAHN >A> AB 20MG A 090383 003 Sep 16, 2011 Mar CAHN >A> AB 40MG A 090383 004 Sep 16, 2011 Mar CAHN >A> AB 80MG A 090383 005 Sep 16, 2011 Mar CAHN >D> AB VIVA HLTHCARE 5MG A 090383 001 Sep 16, 2011 Mar CAHN >D> AB 10MG A 090383 002 Sep 16, 2011 Mar CAHN >D> AB 20MG A 090383 003 Sep 16, 2011 Mar CAHN >D> AB 40MG A 090383 004 Sep 16, 2011 Mar CAHN >D> AB 80MG A 090383 005 Sep 16, 2011 Mar CAHN

>A> SIPONIMOD >A> TABLET;ORAL >A> MAYZENT >A> + NOVARTIS PHARMS CORP 0.25MG N 209884 001 Mar 26, 2019 Mar NEWA >A> +! 2MG N 209884 002 Mar 26, 2019 Mar NEWA

SODIUM NITROPRUSSIDE INJECTABLE;INJECTION SODIUM NITROPRUSSIDE >A> AP DR REDDYS LABS LTD 25MG/ML A 210114 001 Apr 10, 2019 Mar NEWA

STAVUDINE >D> FOR SOLUTION;ORAL >D> ZERIT >D> +! BRISTOL-MYERS SQUIBB 1MG/ML N 020413 001 Sep 06, 1996 Mar DISC >A> + @ 1MG/ML N 020413 001 Sep 06, 1996 Mar DISC

TADALAFIL TABLET;ORAL TADALAFIL >A> AB ACCORD HLTHCARE 2.5MG A 209167 001 Mar 26, 2019 Mar NEWA >A> AB 5MG A 209167 002 Mar 26, 2019 Mar NEWA >A> AB1 20MG A 209167 004 Mar 26, 2019 Mar NEWA >A> AB AJANTA PHARMA LTD 2.5MG A 209654 001 Mar 26, 2019 Mar NEWA >A> AB 5MG A 209654 002 Mar 26, 2019 Mar NEWA

Page 23 of 30 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

TADALAFIL TABLET;ORAL TADALAFIL >A> AB 10MG A 209654 003 Mar 26, 2019 Mar NEWA >A> AB1 20MG A 209654 004 Mar 26, 2019 Mar NEWA >A> AB ALEMBIC PHARMS LTD 2.5MG A 204809 001 Mar 26, 2019 Mar NEWA >A> AB 5MG A 204809 002 Mar 26, 2019 Mar NEWA >A> AB 10MG A 204809 003 Mar 26, 2019 Mar NEWA >A> AB1 20MG A 204809 004 Mar 26, 2019 Mar NEWA >A> AB AMNEAL PHARMS CO 2.5MG A 209744 001 Mar 26, 2019 Mar NEWA >A> AB 5MG A 209744 002 Mar 26, 2019 Mar NEWA >A> AB 10MG A 209744 003 Mar 26, 2019 Mar NEWA >A> AB1 20MG A 209744 004 Mar 26, 2019 Mar NEWA >A> AB AUROBINDO PHARMA LTD 2.5MG A 206285 001 Mar 26, 2019 Mar NEWA >A> AB 5MG A 206285 002 Mar 26, 2019 Mar NEWA >A> AB 10MG A 206285 003 Mar 26, 2019 Mar NEWA >A> AB1 20MG A 206285 004 Mar 26, 2019 Mar NEWA >A> AB CIPLA 2.5MG A 209539 001 Mar 26, 2019 Mar NEWA >A> AB 5MG A 209539 002 Mar 26, 2019 Mar NEWA >A> AB 10MG A 209539 003 Mar 26, 2019 Mar NEWA >A> AB1 20MG A 209539 004 Mar 26, 2019 Mar NEWA >A> AB DR REDDYS LABS LTD 2.5MG A 210069 001 Mar 26, 2019 Mar NEWA >A> AB 5MG A 210069 002 Mar 26, 2019 Mar NEWA >A> AB 10MG A 210069 003 Mar 26, 2019 Mar NEWA >A> AB1 20MG A 210069 004 Mar 26, 2019 Mar NEWA >A> AB HETERO LABS LTD III 2.5MG A 209908 001 Mar 26, 2019 Mar NEWA >A> AB 5MG A 209908 002 Mar 26, 2019 Mar NEWA >A> AB 10MG A 209908 003 Mar 26, 2019 Mar NEWA >A> AB1 20MG A 209908 004 Mar 26, 2019 Mar NEWA >A> AB LUPIN LTD 2.5MG A 210567 001 Mar 26, 2019 Mar NEWA >A> AB 5MG A 210567 002 Mar 26, 2019 Mar NEWA >A> AB 10MG A 210567 003 Mar 26, 2019 Mar NEWA >A> AB1 20MG A 210567 004 Mar 26, 2019 Mar NEWA >A> AB QILU PHARM CO LTD 2.5MG A 210420 001 Mar 26, 2019 Mar NEWA >A> AB 5MG A 210420 002 Mar 26, 2019 Mar NEWA >A> AB 10MG A 210420 003 Mar 26, 2019 Mar NEWA >A> AB1 20MG A 210420 004 Mar 26, 2019 Mar NEWA >A> AB SUN PHARM 2.5MG A 208934 001 Mar 26, 2019 Mar NEWA >A> AB 5MG A 208934 002 Mar 26, 2019 Mar NEWA >A> AB 10MG A 208934 003 Mar 26, 2019 Mar NEWA >A> AB1 20MG A 208934 004 Mar 26, 2019 Mar NEWA >A> AB SUNSHINE LAKE 2.5MG A 211335 001 Mar 26, 2019 Mar NEWA >A> AB 5MG A 211335 002 Mar 26, 2019 Mar NEWA >A> AB 10MG A 211335 003 Mar 26, 2019 Mar NEWA >A> AB1 20MG A 211335 004 Mar 26, 2019 Mar NEWA >A> AB TORRENT 2.5MG A 211839 001 Mar 26, 2019 Mar NEWA >A> AB 5MG A 211839 002 Mar 26, 2019 Mar NEWA >A> AB 10MG A 211839 003 Mar 26, 2019 Mar NEWA >A> AB1 20MG A 211839 004 Mar 26, 2019 Mar NEWA >A> AB2 20MG A 212062 001 Mar 26, 2019 Mar NEWA >A> AB UNICHEM LABS LTD 2.5MG A 209250 001 Mar 26, 2019 Mar NEWA >A> AB 5MG A 209250 002 Mar 26, 2019 Mar NEWA >A> AB 10MG A 209250 003 Mar 26, 2019 Mar NEWA >A> AB1 20MG A 209250 004 Mar 26, 2019 Mar NEWA >A> AB WATSON LABS INC 2.5MG A 205885 001 Mar 29, 2019 Mar NEWA >A> AB 5MG A 205885 002 Mar 29, 2019 Mar NEWA >A> AB 10MG A 205885 003 Mar 29, 2019 Mar NEWA >A> AB1 20MG A 205885 004 Mar 29, 2019 Mar NEWA >A> AB ZYDUS PHARMS 2.5MG A 206693 001 Mar 26, 2019 Mar NEWA >A> AB 5MG A 206693 002 Mar 26, 2019 Mar NEWA >A> AB 10MG A 206693 003 Mar 26, 2019 Mar NEWA >A> AB1 20MG A 206693 004 Mar 26, 2019 Mar NEWA

Page 24 of 30 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

TELMISARTAN TABLET;ORAL TELMISARTAN >D> AB MICRO LABS 20MG A 207016 001 Oct 03, 2017 Mar DISC >A> @ 20MG A 207016 001 Oct 03, 2017 Mar DISC >D> AB 40MG A 207016 002 Oct 03, 2017 Mar DISC >A> @ 40MG A 207016 002 Oct 03, 2017 Mar DISC >D> AB 80MG A 207016 003 Oct 03, 2017 Mar DISC >A> @ 80MG A 207016 003 Oct 03, 2017 Mar DISC

TERAZOSIN HYDROCHLORIDE CAPSULE;ORAL TERAZOSIN HYDROCHLORIDE >A> AB HERITAGE PHARMA EQ 1MG BASE A 075614 002 Jan 30, 2001 Mar CAHN >A> AB EQ 2MG BASE A 075614 001 Jan 30, 2001 Mar CAHN >A> AB EQ 5MG BASE A 075614 003 Jan 30, 2001 Mar CAHN >A> AB EQ 10MG BASE A 075614 004 Jan 30, 2001 Mar CAHN >D> AB IVAX SUB TEVA PHARMS EQ 1MG BASE A 075614 002 Jan 30, 2001 Mar CAHN >D> AB EQ 2MG BASE A 075614 001 Jan 30, 2001 Mar CAHN >D> AB EQ 5MG BASE A 075614 003 Jan 30, 2001 Mar CAHN >D> AB EQ 10MG BASE A 075614 004 Jan 30, 2001 Mar CAHN

TERIFLUNOMIDE TABLET;ORAL TERIFLUNOMIDE >D> AB TEVA PHARMS USA 7MG A 209700 001 Sep 04, 2018 Mar DISC >A> @ 7MG A 209700 001 Sep 04, 2018 Mar DISC >D> AB 14MG A 209700 002 Sep 04, 2018 Mar DISC >A> @ 14MG A 209700 002 Sep 04, 2018 Mar DISC

TESTOSTERONE GEL, METERED;TRANSDERMAL TESTOSTERONE >A> AB ACTAVIS LABS UT INC 1.62% (20.25MG/1.25GM A 204570 001 Apr 10, 2019 Mar NEWA ACTUATION) >A> AB AMNEAL PHARMS LLC 1.62% (20.25MG/1.25GM A 207373 001 Apr 10, 2019 Mar NEWA ACTUATION) >A> AB DR REDDYS LABS INC 1.62% (20.25MG/1.25GM A 208620 001 Apr 10, 2019 Mar NEWA ACTUATION) >A> AB LUPIN ATLANTIS 1.62% (20.25MG/1.25GM A 208560 001 Apr 10, 2019 Mar NEWA ACTUATION) GEL;TRANSDERMAL TESTOSTERONE >D> AB1 PAR PHARM 25MG/2.5GM PACKET A 076744 001 May 23, 2007 Mar DISC >A> @ 25MG/2.5GM PACKET A 076744 001 May 23, 2007 Mar DISC

TESTOSTERONE CYPIONATE INJECTABLE;INJECTION TESTOSTERONE CYPIONATE >D> AO MYLAN INSTITUTIONAL 200MG/ML A 040652 001 Dec 11, 2006 Mar DISC >A> @ 200MG/ML A 040652 001 Dec 11, 2006 Mar DISC

TESTOSTERONE UNDECANOATE >A> CAPSULE;ORAL >A> JATENZO >A> + CLARUS 158MG N 206089 001 Mar 27, 2019 Mar NEWA >A> + 198MG N 206089 002 Mar 27, 2019 Mar NEWA >A> +! 237MG N 206089 003 Mar 27, 2019 Mar NEWA

TETRABENAZINE TABLET;ORAL TETRABENAZINE >A> AB WEST-WARD PHARMS INT 12.5MG A 209739 001 Apr 08, 2019 Mar NEWA >A> AB 25MG A 209739 002 Apr 08, 2019 Mar NEWA

TETRACAINE HYDROCHLORIDE SOLUTION;OPHTHALMIC TETRACAINE HYDROCHLORIDE >A> VALEANT PHARMS 0.5% N 210821 001 Mar 12, 2019 Mar NEWA

Page 25 of 30 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

THIOTHIXENE CAPSULE;ORAL THIOTHIXENE >D> MYLAN 1MG A 071093 002 Jun 23, 1987 Mar CTEC >A> AB 1MG A 071093 002 Jun 23, 1987 Mar CTEC >D> 2MG A 071093 003 Jun 23, 1987 Mar CTEC >A> AB 2MG A 071093 003 Jun 23, 1987 Mar CTEC >D> ! 5MG A 071093 004 Jun 23, 1987 Mar CTEC >A> AB ! 5MG A 071093 004 Jun 23, 1987 Mar CTEC >D> 10MG A 071093 001 Jun 23, 1987 Mar CTEC >A> AB 10MG A 071093 001 Jun 23, 1987 Mar CTEC >A> AB NOVITIUM PHARMA 1MG A 211642 001 Apr 05, 2019 Mar NEWA >A> AB 2MG A 211642 002 Apr 05, 2019 Mar NEWA >A> AB 5MG A 211642 003 Apr 05, 2019 Mar NEWA >A> AB 10MG A 211642 004 Apr 05, 2019 Mar NEWA

TIZANIDINE HYDROCHLORIDE CAPSULE;ORAL TIZANIDINE HYDROCHLORIDE >A> AB ALKEM LABS LTD EQ 2MG BASE A 212196 001 Mar 27, 2019 Mar NEWA >A> AB EQ 4MG BASE A 212196 002 Mar 27, 2019 Mar NEWA >A> AB EQ 6MG BASE A 212196 003 Mar 27, 2019 Mar NEWA >A> AB CADILA PHARMS LTD EQ 2MG BASE A 210021 001 Mar 26, 2019 Mar NEWA >A> AB EQ 4MG BASE A 210021 002 Mar 26, 2019 Mar NEWA >A> AB EQ 6MG BASE A 210021 003 Mar 26, 2019 Mar NEWA TABLET;ORAL TIZANIDINE HYDROCHLORIDE >D> AB PAR PHARM INC EQ 2MG BASE A 207170 001 Jan 26, 2017 Mar DISC >A> @ EQ 2MG BASE A 207170 001 Jan 26, 2017 Mar DISC >D> AB EQ 4MG BASE A 207170 002 Jan 26, 2017 Mar DISC >A> @ EQ 4MG BASE A 207170 002 Jan 26, 2017 Mar DISC

TOBRAMYCIN SOLUTION;INHALATION TOBRAMYCIN >D> @ DR REDDYS LABS SA 300MG/5ML A 207080 001 Jul 09, 2018 Mar CMFD >A> AN 300MG/5ML A 207080 001 Jul 09, 2018 Mar CMFD

TOLCAPONE TABLET;ORAL TASMAR >A> AB +! BAUSCH 100MG N 020697 001 Jan 29, 1998 Mar CAHN >A> @ 200MG N 020697 002 Jan 29, 1998 Mar CAHN >D> AB +! VALEANT PHARMS LLC 100MG N 020697 001 Jan 29, 1998 Mar CAHN >D> @ 200MG N 020697 002 Jan 29, 1998 Mar CAHN

TRANEXAMIC ACID INJECTABLE;INJECTION TRANEXAMIC ACID >A> AP MICRO LABS 100MG/ML A 206713 001 Jun 27, 2017 Mar CAHN >D> AP VIVA HLTHCARE 100MG/ML A 206713 001 Jun 27, 2017 Mar CAHN

TRIAMCINOLONE ACETONIDE INJECTABLE;INJECTION TRIAMCINOLONE ACETONIDE >D> AB TEVA PHARMS USA 40MG/ML A 209852 001 Oct 05, 2018 Mar DISC >A> @ 40MG/ML A 209852 001 Oct 05, 2018 Mar DISC

VASOPRESSIN >A> SOLUTION;INTRAVENOUS >A> VASOSTRICT >A> +! PAR STERILE PRODUCTS 20UNITS/ML (20UNITS/ML) N 204485 001 Apr 17, 2014 Mar CDFR >A> +! 200UNITS/10ML (20UNITS/ML) N 204485 002 Dec 17, 2016 Mar CDFR >D> SOLUTION;IV (INFUSION) >D> VASOSTRICT >D> +! PAR STERILE PRODUCTS 20UNITS/ML (20UNITS/ML) N 204485 001 Apr 17, 2014 Mar CDFR >D> +! 200UNITS/10ML (20UNITS/ML) N 204485 002 Dec 17, 2016 Mar CDFR

Page 26 of 30 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

VIGABATRIN FOR SOLUTION;ORAL VIGADRONE >D> AA AUCTA PHARMS 500MG/PACKET A 210196 001 Jun 21, 2018 Mar CAHN >A> AA SHANGHAI 500MG/PACKET A 210196 001 Jun 21, 2018 Mar CAHN

VINCRISTINE SULFATE INJECTABLE, LIPOSOMAL;INTRAVENOUS MARQIBO KIT >A> +! ACROTECH 5MG/5ML (1MG/ML) N 202497 001 Aug 09, 2012 Mar CAHN >D> +! TALON THERAP 5MG/5ML (1MG/ML) N 202497 001 Aug 09, 2012 Mar CAHN

VINORELBINE TARTRATE INJECTABLE;INJECTION VINORELBINE TARTRATE >D> AP HOSPIRA EQ 10MG BASE/ML A 076827 001 Jun 02, 2005 Mar DISC >A> @ EQ 10MG BASE/ML A 076827 001 Jun 02, 2005 Mar DISC

ZOLEDRONIC ACID >A> INJECTABLE;INTRAVENOUS >A> RECLAST >A> AP +! NOVARTIS EQ 5MG BASE/100ML N 021817 001 Apr 16, 2007 Mar CDFR >A> ZOLEDRONIC >A> AP GLAND PHARMA LTD EQ 4MG BASE/100ML A 205749 001 Jun 29, 2018 Mar CDFR >A> ZOLEDRONIC ACID >A> AP ACCORD HLTHCARE EQ 4MG BASE/5ML A 205279 001 Nov 28, 2016 Mar CDFR >A> AP ACTAVIS INC EQ 4MG BASE/5ML A 202472 001 Mar 04, 2013 Mar CDFR >A> AP AKORN EQ 5MG BASE/100ML A 200918 001 Aug 21, 2014 Mar CDFR >A> AP AKORN INC EQ 4MG BASE/5ML A 202548 001 May 22, 2014 Mar CDFR >A> AP APOTEX INC EQ 5MG BASE/100ML A 204367 001 Dec 24, 2015 Mar CDFR >A> AP AUROBINDO PHARMA LTD EQ 4MG BASE/5ML A 207751 001 Sep 26, 2016 Mar CDFR >A> AP EQ 5MG BASE/100ML A 209125 001 Dec 08, 2017 Mar CDFR >A> AP BPI LABS LLC EQ 4MG BASE/5ML A 207341 001 Dec 29, 2017 Mar CDFR >A> AP BRECKENRIDGE PHARM EQ 4MG BASE/5ML A 091170 001 Mar 04, 2013 Mar CDFR >A> AP EQ 4MG BASE/5ML A 202571 001 May 07, 2013 Mar CDFR >A> AP EQ 5MG BASE/100ML A 202163 001 Aug 05, 2013 Mar CDFR >A> AP CIPLA EQ 4MG BASE/100ML A 210174 001 Oct 27, 2017 Mar CDFR >A> AP DR REDDYS LABS LTD EQ 4MG BASE/100ML A 204344 001 Nov 19, 2018 Mar CDFR >A> AP EQ 5MG BASE/100ML A 091363 001 Mar 29, 2013 Mar CDFR >A> AP EMCURE PHARMS LTD EQ 4MG BASE/5ML A 201783 001 Mar 12, 2013 Mar CDFR >A> AP EQ 5MG BASE/100ML A 201801 001 Mar 29, 2013 Mar CDFR >A> AP FRESENIUS KABI USA EQ 4MG BASE/5ML A 091516 001 Apr 23, 2015 Mar CDFR >A> AP GLAND PHARMA LTD EQ 4MG BASE/5ML A 202930 001 Aug 05, 2013 Mar CDFR >A> AP EQ 5MG BASE/100ML A 204217 001 Aug 18, 2016 Mar CDFR >A> AP HIKMA FARMACEUTICA EQ 4MG BASE/5ML A 202182 001 Jun 03, 2013 Mar CDFR >A> AP HOSPIRA INC EQ 4MG BASE/5ML A 090621 001 Mar 19, 2015 Mar CDFR >A> AP EQ 5MG BASE/100ML A 202837 001 Apr 05, 2013 Mar CDFR >A> AP INFORLIFE EQ 4MG BASE/100ML N 203231 001 Aug 02, 2013 Mar CDFR >A> AP EQ 5MG BASE/100ML A 202828 001 Sep 23, 2013 Mar CDFR >A> AP MYLAN LABS LTD EQ 4MG BASE/5ML A 202650 001 Mar 04, 2013 Mar CDFR >A> AP EQ 5MG BASE/100ML A 203841 001 Feb 14, 2017 Mar CDFR >A> AP EQ 5MG BASE/100ML A 205254 001 Oct 27, 2017 Mar CDFR >A> AP SAGENT PHARMS EQ 4MG BASE/5ML A 091493 001 Nov 24, 2014 Mar CDFR >A> @ SUN PHARMA GLOBAL EQ 4MG BASE/VIAL A 090018 001 Mar 04, 2013 Mar CDFR >A> @ EQ 4MG BASE/5ML A 202746 001 Mar 04, 2013 Mar CDFR >A> AP USV NORTH AMERICA EQ 4MG BASE/5ML A 202923 001 Sep 04, 2014 Mar CDFR >A> ZOMETA >A> + @ NOVARTIS EQ 4MG BASE/VIAL N 021223 001 Aug 20, 2001 Mar CDFR >A> AP +! EQ 4MG BASE/5ML N 021223 002 Mar 07, 2003 Mar CDFR >A> AP +! EQ 4MG BASE/100ML N 021223 003 Jun 17, 2011 Mar CDFR >D> INJECTABLE;IV (INFUSION) >D> RECLAST >D> AP +! NOVARTIS EQ 5MG BASE/100ML N 021817 001 Apr 16, 2007 Mar CDFR >D> ZOLEDRONIC >D> AP GLAND PHARMA LTD EQ 4MG BASE/100ML A 205749 001 Jun 29, 2018 Mar CDFR >D> ZOLEDRONIC ACID >D> AP ACCORD HLTHCARE EQ 4MG BASE/5ML A 205279 001 Nov 28, 2016 Mar CDFR >D> AP ACTAVIS INC EQ 4MG BASE/5ML A 202472 001 Mar 04, 2013 Mar CDFR >D> AP AKORN EQ 5MG BASE/100ML A 200918 001 Aug 21, 2014 Mar CDFR >D> AP AKORN INC EQ 4MG BASE/5ML A 202548 001 May 22, 2014 Mar CDFR

Page 27 of 30 ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST

ZOLEDRONIC ACID >D> INJECTABLE;IV (INFUSION) >D> ZOLEDRONIC ACID >D> AP APOTEX INC EQ 5MG BASE/100ML A 204367 001 Dec 24, 2015 Mar CDFR >D> AP AUROBINDO PHARMA LTD EQ 4MG BASE/5ML A 207751 001 Sep 26, 2016 Mar CDFR >D> AP EQ 5MG BASE/100ML A 209125 001 Dec 08, 2017 Mar CDFR >D> AP BPI LABS LLC EQ 4MG BASE/5ML A 207341 001 Dec 29, 2017 Mar CDFR >D> AP BRECKENRIDGE PHARM EQ 4MG BASE/5ML A 091170 001 Mar 04, 2013 Mar CDFR >D> AP EQ 4MG BASE/5ML A 202571 001 May 07, 2013 Mar CDFR >D> AP EQ 5MG BASE/100ML A 202163 001 Aug 05, 2013 Mar CDFR >D> AP CIPLA EQ 4MG BASE/100ML A 210174 001 Oct 27, 2017 Mar CDFR >D> AP DR REDDYS LABS LTD EQ 4MG BASE/5ML A 091186 001 Mar 04, 2013 Mar CDFR >A> AP EQ 4MG BASE/5ML A 091186 001 Mar 04, 2013 Mar CDFR >D> AP EQ 4MG BASE/100ML A 204344 001 Nov 19, 2018 Mar CDFR >D> AP EQ 5MG BASE/100ML A 091363 001 Mar 29, 2013 Mar CDFR >D> AP EMCURE PHARMS LTD EQ 4MG BASE/5ML A 201783 001 Mar 12, 2013 Mar CDFR >D> AP EQ 5MG BASE/100ML A 201801 001 Mar 29, 2013 Mar CDFR >D> AP FRESENIUS KABI USA EQ 4MG BASE/5ML A 091516 001 Apr 23, 2015 Mar CDFR >D> AP GLAND PHARMA LTD EQ 4MG BASE/5ML A 202930 001 Aug 05, 2013 Mar CDFR >D> AP EQ 5MG BASE/100ML A 204217 001 Aug 18, 2016 Mar CDFR >D> AP HIKMA FARMACEUTICA EQ 4MG BASE/5ML A 202182 001 Jun 03, 2013 Mar CDFR >D> AP HOSPIRA INC EQ 4MG BASE/5ML A 090621 001 Mar 19, 2015 Mar CDFR >D> AP EQ 5MG BASE/100ML A 202837 001 Apr 05, 2013 Mar CDFR >D> AP INFORLIFE EQ 4MG BASE/100ML N 203231 001 Aug 02, 2013 Mar CDFR >D> AP EQ 5MG BASE/100ML A 202828 001 Sep 23, 2013 Mar CDFR >D> AP MYLAN LABS LTD EQ 4MG BASE/5ML A 202650 001 Mar 04, 2013 Mar CDFR >D> AP EQ 5MG BASE/100ML A 203841 001 Feb 14, 2017 Mar CDFR >D> AP EQ 5MG BASE/100ML A 205254 001 Oct 27, 2017 Mar CDFR >D> AP SAGENT PHARMS EQ 4MG BASE/5ML A 091493 001 Nov 24, 2014 Mar CDFR >D> @ SUN PHARMA GLOBAL EQ 4MG BASE/VIAL A 090018 001 Mar 04, 2013 Mar CDFR >D> @ EQ 4MG BASE/5ML A 202746 001 Mar 04, 2013 Mar CDFR >D> AP USV NORTH AMERICA EQ 4MG BASE/5ML A 202923 001 Sep 04, 2014 Mar CDFR >D> ZOMETA >D> + @ NOVARTIS EQ 4MG BASE/VIAL N 021223 001 Aug 20, 2001 Mar CDFR >D> AP +! EQ 4MG BASE/5ML N 021223 002 Mar 07, 2003 Mar CDFR >D> AP +! EQ 4MG BASE/100ML N 021223 003 Jun 17, 2011 Mar CDFR >A> SOLUTION;INTRAVENOUS >A> ZOLEDRONIC ACID >A> HOSPIRA INC EQ 4MG BASE/100ML (EQ 0.04MG N 204016 001 Dec 28, 2015 Mar CDFR BASE/ML) >D> SOLUTION;IV (INFUSION) >D> ZOLEDRONIC ACID >D> HOSPIRA INC EQ 4MG BASE/100ML (EQ 0.04MG N 204016 001 Dec 28, 2015 Mar CDFR BASE/ML)

ZOLPIDEM TARTRATE TABLET;SUBLINGUAL >D> INTERMEZZO >D> AB + PURDUE PHARMA 1.75MG N 022328 001 Nov 23, 2011 Mar DISC >A> + @ 1.75MG N 022328 001 Nov 23, 2011 Mar DISC >D> AB +! 3.5MG N 022328 002 Nov 23, 2011 Mar DISC >A> + @ 3.5MG N 022328 002 Nov 23, 2011 Mar DISC ZOLPIDEM TARTRATE >D> AB NOVEL LABS INC 3.5MG A 204299 002 Jun 03, 2015 Mar CHRS >A> AB ! 3.5MG A 204299 002 Jun 03, 2015 Mar CHRS

Page 28 of 30 ADDITIONS/DELETIONS FOR OTC DRUG PRODUCT LIST

ACETAMINOPHEN TABLET, EXTENDED RELEASE;ORAL ACETAMINOPHEN >D> HERITAGE PHARMA 650MG A 207035 001 May 31, 2018 Mar DISC >A> @ 650MG A 207035 001 May 31, 2018 Mar DISC

GUAIFENESIN TABLET, EXTENDED RELEASE;ORAL GUAIFENESIN >D> OHM LABS INC 600MG A 209254 001 Jul 16, 2018 Mar DISC >A> @ 600MG A 209254 001 Jul 16, 2018 Mar DISC >D> 1.2GM A 209254 002 Jul 16, 2018 Mar DISC >A> @ 1.2GM A 209254 002 Jul 16, 2018 Mar DISC

LEVOCETIRIZINE DIHYDROCHLORIDE TABLET;ORAL LEVOCETIRIZINE DIHYDROCHLORIDE >A> PERRIGO R AND D 5MG A 211983 001 Mar 26, 2019 Mar NEWA

LORATADINE CAPSULE;ORAL LORATADINE >D> BIONPHARMA INC 10MG A 202538 001 Dec 21, 2018 Mar DISC >A> @ 10MG A 202538 001 Dec 21, 2018 Mar DISC TABLET, CHEWABLE;ORAL LORATADINE >A> SUN PHARM 5MG A 210088 001 Apr 16, 2018 Mar CAHN >D> SUN PHARMA GLOBAL 5MG A 210088 001 Apr 16, 2018 Mar CAHN TABLET;ORAL LORATADINE >A> GUARDIAN DRUG 10MG A 207569 001 Mar 12, 2019 Mar CAHN >D> NEWGEN PHARMS LLC 10MG A 207569 001 Mar 12, 2019 Mar CAHN

NAPROXEN SODIUM; PSEUDOEPHEDRINE HYDROCHLORIDE TABLET, EXTENDED RELEASE;ORAL ALEVE-D SINUS & COLD >D> +! BAYER 200MG;120MG N 021076 001 Nov 29, 1999 Mar CPOT >A> +! EQ 200MG BASE;120MG N 021076 001 Nov 29, 1999 Mar CPOT

>D> SODIUM FLUORIDE; TRICLOSAN >D> PASTE;DENTAL >D> COLGATE TOTAL >D> +! COLGATE PALMOLIVE 0.24%;0.3% N 020231 001 Jul 11, 1997 Mar DISC >A> + @ 0.24%;0.3% N 020231 001 Jul 11, 1997 Mar DISC

Page 29 of 30 CURRENT MONTH ADDS/DELETES LIST NOTE:

The List is sorted by Ingredient(s) and, within each grouping, by the Dosage Form; Route and then by trade name.

The individual product record contains the Therapeutic Equivalence Code, Reference Listed Drug symbol, Reference Standard Drug symbol, applicant holder, strength(s), New Drug Application number, product number, and approval date. The last two columns describe the action. The Action Month is the CS month the action occurred. The OB Action is the type of change that has occurred.

New ingredient(s), new dosage form; route(s), new trade names, and new product additions are preceded by >A> during the action month. The change month is the current CS month; the change code for new approvals is NEWA.

Changes to currently listed products will list two records. The deleted product record will be proceeded by >D>. The product record change addition being made will be preceded by >A>.

The change code description:

NEWA New drug product approval usually in the supplement month. NFTG New first time generic approval. CAHN** Applicant holder firm name has changed. CAIN Change. There has been a change in the Ingredient(s) name. All products will be deleted under the old name and all products will be added under the changed ingredient(s) name. CDFR Change. Dosage Form; Route of Administration. CFTG Change. A first time generic for the innovator product. A TE Code is added. CMFD Change. The product is moved from the Discontinued Section due to a change in marketing status. CMS1 Change. Miscellaneous addition to list. CMS2 Change. Miscellaneous deletion from list. CPOT Change. Potency amount/unit. CRLD Change. Reference Listed Drug. CHRS Change. Reference Standard. CTEC Change. Therapeutic Equivalence Code. CTNA Change. Trade Name. DISC Discontinued. The Rx or OTC listed product is not being marketed and will be moved to the discontinued section in the next edition.

**Note: The Cumulative Supplement (CS) currently displays a condensed 20 character collapsed applicant holder firm name and the Electronic Orange Book(EOB)query may display up to a 240 character full applicant holder firm name. An applicant holder firm name change usually changes both the collapsed name and long name. On occasion, only the long name is changed resulting in the CS displaying only the collapsed name for the >D> and >A> action. The new firm long name will display in the EOB query.

Page 30 of 30